CDK6
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| O00115 | S70 | Sugiyama | DNASE2 DNASE2A DNL2 | QYKyLDEssGGWRDGRALINsPEGAVGRSLQPLyRSNTSQL |
| O00151 | S90 | Sugiyama | PDLIM1 CLIM1 CLP36 | IKGCTDNLtLtVARsEHKVWsPLVtEEGKRHPYKMNLASEP |
| O14745 | S280 | Sugiyama | NHERF1 NHERF SLC9A3R1 | tNGEIQKENsREALAEAALEsPRPALVRsAssDtsEELNsQ |
| O14910 | S130 | Sugiyama | LIN7A MALS1 VELI1 | ELPKTDEGLGFNVMGGKEQNsPIyIsRIIPGGVAERHGGLK |
| O43852 | S261 | Sugiyama | CALU | RDKNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNK |
| O43852 | T65 | Sugiyama | CALU | FDyDHDAFLGAEEAKtFDQLtPEEsKERLGKIVSKIDGDKD |
| O60292 | S158 | Sugiyama | SIPA1L3 KIAA0545 SPAL3 | FHRLSRRRsKDVEFQDGWPRsPGRAFLPLRHRsssEItLSE |
| O95425 | S245 | Sugiyama | SVIL | EsssTFsFSGRDssFtEVPRsPKHAHSssLQQAAsRsPsFG |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00558 | T168 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGF |
| P03973 | T78 | Sugiyama | SLPI WAP4 WFDC4 | PGKKRCCPDTCGIKCLDPVDtPNPTRRKPGKCPVTYGQCLM |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04083 | S170 | Sugiyama | ANXA1 ANX1 LPC1 | RDINRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRsE |
| P04406 | S210 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GPsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtG |
| P04406 | T211 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | PsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtGM |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P06400 | S249 | PSP | RB1 | LsPPMLLKEPYKTAVIPINGsPRtPRRGQNRSARIAKQLEN |
| P06400 | S612 | EPSD|PSP | RB1 | LNLPLQNNHtAADMyLsPVRsPKKKGSTTRVNstANAETQA |
| P06400 | S780 | EPSD|PSP | RB1 | FMQRLKtNILQyAstRPPtLsPIPHIPRsPyKFPssPLRIP |
| P06400 | S788 | EPSD|PSP | RB1 | ILQyAstRPPtLsPIPHIPRsPyKFPssPLRIPGGNIyIsP |
| P06400 | S795 | EPSD|PSP | RB1 | RPPtLsPIPHIPRsPyKFPssPLRIPGGNIyIsPLKsPYKI |
| P06400 | S807 | EPSD|PSP | RB1 | RsPyKFPssPLRIPGGNIyIsPLKsPYKIsEGLPtPtKMtP |
| P06400 | S811 | SIGNOR|EPSD|PSP | RB1 | KFPssPLRIPGGNIyIsPLKsPYKIsEGLPtPtKMtPRSRI |
| P06400 | T252 | PSP | RB1 | PMLLKEPYKTAVIPINGsPRtPRRGQNRSARIAKQLENDTR |
| P06400 | T821 | GPS6|EPSD|PSP | RB1 | GGNIyIsPLKsPYKIsEGLPtPtKMtPRSRILVSIGEsFGt |
| P06400 | T826 | EPSD|PSP | RB1 | IsPLKsPYKIsEGLPtPtKMtPRSRILVSIGEsFGtsEKFQ |
| P06733 | S263 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GMDVAASEFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsF |
| P06733 | S272 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | FRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsI |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06733 | Y280 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | DFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsIEDPFDQDD |
| P06748 | T199 | GPS6|EPSD|PSP | NPM1 NPM | DDFDDEEAEEKAPVKKsIRDtPAKNAQKSNQNGKDsKPsst |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | T302 | Sugiyama | LDHB | YGIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsAD |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07205 | T168 | Sugiyama | PGK2 PGKB | EAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNLPHKASGF |
| P07237 | Y94 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPK |
| P07858 | S216 | Sugiyama | CTSB CPSB | PPCTGEGDTPKCSKICEPGysPtyKQDKHYGYNSYSVSNSE |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07900 | S391 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MDNCEELIPEYLNFIRGVVDsEDLPLNIsREMLQQsKILKV |
| P07900 | S53 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDsG |
| P08195 | S598 | Sugiyama | SLC3A2 MDU1 | LQASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEP |
| P08195 | S607 | Sugiyama | SLC3A2 MDU1 | ASLPAKADLLLstQPGREEGsPLELERLKLEPHEGLLLRFP |
| P08238 | S383 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MDSCDELIPEYLNFIRGVVDsEDLPLNIsREMLQQsKILKV |
| P08758 | T10 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | ___________MAQVLRGtVtDFPGFDERADAEtLRKAMKG |
| P09234 | S17 | Sugiyama | SNRPC | ____MPKFyCDyCDtyLtHDsPsVRKTHCSGRKHKENVKDY |
| P10809 | S453 | Sugiyama | HSPD1 HSP60 | EEGIVLGGGCALLRCIPALDsLtPANEDQKIGIEIIKRTLK |
| P10809 | S70 | Sugiyama | HSPD1 HSP60 | AVAVTMGPKGRtVIIEQsWGsPKVTKDGVtVAKsIDLKDKY |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11142 | T38 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P11142 | T45 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtN |
| P11142 | T64 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FtDtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQ |
| P11142 | T66 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQsD |
| P11142 | Y41 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P12270 | S2155 | Sugiyama | TPR | PstPtLVVPHRtDGFAEAIHsPQVAGVPRFRFGPPEDMPQT |
| P12277 | T35 | Sugiyama | CKB CKBB | PAEDEFPDLSAHNNHMAKVLtPELyAELRAKSTPSGFTLDD |
| P12277 | Y39 | Sugiyama | CKB CKBB | EFPDLSAHNNHMAKVLtPELyAELRAKSTPSGFTLDDVIQT |
| P13639 | S593 | Sugiyama | EEF2 EF2 | SDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGL |
| P13639 | S595 | Sugiyama | EEF2 EF2 | PVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGLAE |
| P13639 | T5 | Sugiyama | EEF2 EF2 | ________________MVNFtVDQIRAIMDKKANIRNMsVI |
| P14618 | S202 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | SLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVs |
| P14618 | S37 | SIGNOR|PSP | PKM OIP3 PK2 PK3 PKM2 | QLHAAMADTFLEHMCRLDIDsPPItARNtGIICtIGPAsRs |
| P17066 | T47 | Sugiyama | HSPA6 HSP70B' | RVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHN |
| P18669 | S31 | Sugiyama | PGAM1 PGAMA CDABP0006 | HGEsAWNLENRFsGWyDADLsPAGHEEAKRGGQALRDAGyE |
| P18858 | S51 | Sugiyama | LIG1 | TEPPPKAALKEWNGVVsEsDsPVKRPGRKAARVLGsEGEEE |
| P19484 | S114 | PSP | TFEB BHLHE35 | EYLsEtYGNKFAAHIsPAQGsPKPPPAAsPGVRAGHVLSss |
| P19484 | S142 | PSP | TFEB BHLHE35 | sPGVRAGHVLSssAGNsAPNsPMAMLHIGsNPERELDDVID |
| P19484 | S467 | PSP | TFEB BHLHE35 | SDPLLstMsPEAsKAssRRssFsMEEGDVL___________ |
| P19484 | T331 | PSP | TFEB BHLHE35 | QLWLRIQELEMQARVHGLPttsPsGMNMAELAQQVVKQELP |
| P19532 | S246 | PSP | TFE3 BHLHE33 | QPLPAPEAAHTTGPTGSAPNsPMALLTIGSSSEKEIDDVID |
| P21333 | S1084 | Sugiyama | FLNA FLN FLN1 | PTKPSKVKAFGPGLQGGsAGsPARFtIDTKGAGTGGLGLTV |
| P21333 | S1459 | PSP | FLNA FLN FLN1 | KVPVHDVTDASKVKCsGPGLsPGMVRANLPQsFQVDTSKAG |
| P21333 | S2152 | PSP | FLNA FLN FLN1 | VKVTGEGRVKEsITRRRRAPsVANVGsHCDLsLKIPEIsIQ |
| P22234 | S27 | Sugiyama | PAICS ADE2 AIRC PAIS | LNIGKKLYEGKtKEVyELLDsPGKVLLQsKDQItAGNAARK |
| P22626 | S259 | Sugiyama | HNRNPA2B1 HNRPA2B1 | GFGDGyNGyGGGPGGGNFGGsPGyGGGRGGYGGGGPGYGNQ |
| P23396 | T220 | Sugiyama | RPS3 OK/SW-cl.26 | PKKPLPDHVsIVEPKDEILPttPIsEQKGGKPEPPAMPQPV |
| P23396 | T221 | Sugiyama | RPS3 OK/SW-cl.26 | KKPLPDHVsIVEPKDEILPttPIsEQKGGKPEPPAMPQPVP |
| P23528 | T63 | Sugiyama | CFL1 CFL | DKKNIILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyA |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P25205 | T722 | Sugiyama | MCM3 | GDsyDPyDFsDtEEEMPQVHtPKTADsQEtKEsQKVELsES |
| P25786 | S14 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | _______MFRNQyDNDVtVWsPQGRIHQIEYAMEAVKQGSA |
| P26038 | S527 | Sugiyama | MSN | ERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHAE |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P27824 | S583 | Sugiyama | CANX | VsQEEEDRKPKAEEDEILNRsPRNRKPRRE___________ |
| P29401 | S295 | Sugiyama | TKT | ysQIQsKKKILAtPPQEDAPsVDIANIRMPsLPsyKVGDKI |
| P29401 | T287 | Sugiyama | TKT | AEQIIQEIysQIQsKKKILAtPPQEDAPsVDIANIRMPsLP |
| P29692 | S133 | Sugiyama | EEF1D EF1D | NVLEKssPGHRAtAPQtQHVsPMRQVEPPAKKPAtPAEDDE |
| P29692 | S162 | Sugiyama | EEF1D EF1D | AKKPAtPAEDDEDDDIDLFGsDNEEEDKEAAQLREERLRQY |
| P29966 | S29 | Sugiyama | MARCKS MACS PRKCSL | AAKGEAAAERPGEAAVAssPsKANGQENGHVKVNGDAsPAA |
| P30086 | T42 | Sugiyama | PEBP1 PBP PEBP | QHPLHVTYAGAAVDELGKVLtPtQVKNRPtsIsWDGLDsGK |
| P30281 | S133 | Sugiyama | CCND3 | LRETtPLtIEKLCIYtDHAVsPRQLRDWEVLVLGKLKWDLA |
| P30281 | S275 | Sugiyama | CCND3 | LREASQTSssPAPKAPRGsssQGPsQtstPtDVtAIHL___ |
| P30281 | S279 | Sugiyama | CCND3 | SQTSssPAPKAPRGsssQGPsQtstPtDVtAIHL_______ |
| P30281 | S282 | Sugiyama | CCND3 | SssPAPKAPRGsssQGPsQtstPtDVtAIHL__________ |
| P30281 | S43 | Sugiyama | CCND3 | GDQRVLQSLLRLEERyVPRAsyFQCVQREIKPHMRKMLAYW |
| P30281 | T120 | Sugiyama | CCND3 | QLLGAVCMLLASKLRETtPLtIEKLCIYtDHAVsPRQLRDW |
| P30281 | T283 | Sugiyama | CCND3 | ssPAPKAPRGsssQGPsQtstPtDVtAIHL___________ |
| P30281 | T285 | Sugiyama | CCND3 | PAPKAPRGsssQGPsQtstPtDVtAIHL_____________ |
| P30281 | T288 | Sugiyama | CCND3 | KAPRGsssQGPsQtstPtDVtAIHL________________ |
| P30281 | Y38 | Sugiyama | CCND3 | DPRLLGDQRVLQSLLRLEERyVPRAsyFQCVQREIKPHMRK |
| P30281 | Y44 | Sugiyama | CCND3 | DQRVLQSLLRLEERyVPRAsyFQCVQREIKPHMRKMLAYWM |
| P30304 | S40 | SIGNOR | CDC25A | PPASQPVVKALFGASAAGGLsPVTNLTVTMDQLQGLGSDyE |
| P30304 | S88 | SIGNOR | CDC25A | NSNLQRMGsSEstDsGFCLDsPGPLDSKENLENPMRRIHsL |
| P31943 | T100 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | HRyVEVFKSNNVEMDWVLKHtGPNsPDtANDGFVRLRGLPF |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P34931 | T40 | Sugiyama | HSPA1L | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P34931 | T47 | Sugiyama | HSPA1L | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQN |
| P34931 | Y43 | Sugiyama | HSPA1L | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P35222 | S45 | SIGNOR|iPTMNet | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | WQQQsyLDsGIHsGATtTAPsLsGKGNPEEEDVDTsQVLyE |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P38646 | T87 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKR |
| P38646 | T94 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | QAKVLENAEGARttPsVVAFtADGERLVGMPAKRQAVtNPN |
| P38936 | S130 | SIGNOR|EPSD|PSP | CDKN1A CAP20 CDKN1 CIP1 MDA6 PIC1 SDI1 WAF1 | HVDLsLSCTLVPRsGEQAEGsPGGPGDSQGRKRRQtsMTDF |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P46527 | S10 | SIGNOR|EPSD|PSP | CDKN1B KIP1 p27 | ___________MSNVRVSNGsPsLERMDARQAEHPKPSACR |
| P46527 | T187 | SIGNOR|EPSD|PSP | CDKN1B KIP1 p27 | ANRTEENVsDGsPNAGSVEQtPKKPGLRRRQt_________ |
| P46777 | S172 | Sugiyama | RPL5 MSTP030 | RTTTGNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNA |
| P46777 | S176 | Sugiyama | RPL5 MSTP030 | GNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHR |
| P46937 | T119 | Sugiyama | YAP1 YAP65 | PEPKsHsRQAstDAGtAGALtPQHVRAHssPAsLQLGAVsP |
| P48741 | T47 | Sugiyama | HSPA7 HSP70B | RVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHN |
| P49736 | T25 | Sugiyama | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | sEsFtMAssPAQRRRGNDPLtssPGRssRRtDALtssPGRD |
| P49815 | S1217 | SIGNOR|PSP | TSC2 TSC4 | ILVRRPTGNTSWLMSLENPLsPFSSDINNMPLQELSNALMA |
| P49815 | S1452 | SIGNOR|PSP | TSC2 TSC4 | ASGEDSRGQPEGPLPsssPRsPsGLRPRGYtIsDsAPsRRG |
| P51812 | S715 | Sugiyama | RPS6KA3 ISPK1 MAPKAPK1B RSK2 | APHLVKGAMAAtysALNRNQsPVLEPVGRsTLAQRRGIKKI |
| P51991 | S358 | Sugiyama | HNRNPA3 HNRPA3 | QQQSNYGPMKGGsFGGRssGsPyGGGyGsGGGsGGyGsRRF |
| P53999 | S118 | Sugiyama | SUB1 PC4 RPO2TC1 | PGRKGIsLNPEQWsQLKEQIsDIDDAVRKL___________ |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P54652 | T39 | Sugiyama | HSPA2 | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P54652 | T46 | Sugiyama | HSPA2 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTN |
| P54652 | Y42 | Sugiyama | HSPA2 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P55795 | T100 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | HRyVEVFKSNsVEMDWVLKHtGPNsPDtANDGFVRLRGLPF |
| P60174 | T38 | Sugiyama | TPI1 TPI | RKQsLGELIGtLNAAKVPADtEVVCAPPtAyIDFARQKLDP |
| P60174 | T46 | Sugiyama | TPI1 TPI | IGtLNAAKVPADtEVVCAPPtAyIDFARQKLDPKIAVAAQN |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | T318 | Sugiyama | ACTB | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P61247 | S263 | Sugiyama | RPS3A FTE1 MFTL | GDEtGAKVERADGyEPPVQEsV___________________ |
| P61978 | S284 | Sugiyama | HNRNPK HNRPK | MPPGRGGRPMPPSRRDyDDMsPRRGPPPPPPGRGGRGGsRA |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P61981 | T31 | Sugiyama | YWHAG | ARLAEQAERyDDMAAAMKNVtELNEPLsNEERNLLsVAyKN |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62263 | T133 | Sugiyama | RPS14 PRO2640 | QsALRALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL__ |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62736 | T320 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62826 | T66 | Sugiyama | RAN ARA24 OK/SW-cl.81 | EVHPLVFHTNRGPIKFNVWDtAGQEKFGGLRDGYYIQAQCA |
| P62942 | S9 | Sugiyama | FKBP1A FKBP1 FKBP12 | ____________MGVQVEtIsPGDGRtFPKRGQtCVVHytG |
| P62942 | T7 | Sugiyama | FKBP1A FKBP1 FKBP12 | ______________MGVQVEtIsPGDGRtFPKRGQtCVVHy |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P63104 | T30 | Sugiyama | YWHAZ | AKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAyKN |
| P63173 | T14 | Sugiyama | RPL38 | _______MPRKIEEIKDFLLtARRKDAKSVKIKKNKDNVKF |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | T318 | Sugiyama | ACTG1 ACTG | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63267 | T319 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68032 | T320 | Sugiyama | ACTC1 ACTC | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68104 | T261 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | PTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKPGMVVtFA |
| P68133 | T320 | Sugiyama | ACTA1 ACTA | VMSGGTTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| P68363 | Y83 | Sugiyama | TUBA1B | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P83731 | T52 | Sugiyama | RPL24 | LNAKCEsAFLSKRNPRQINWtVLyRRKHKKGQsEEIQKKRT |
| P83731 | Y55 | Sugiyama | RPL24 | KCEsAFLSKRNPRQINWtVLyRRKHKKGQsEEIQKKRTRRA |
| P85037 | S420 | Sugiyama | FOXK1 MNF | RGVSCFRtPFGPLssRsAPAsPtHPGLMsPRsGGLQtPECL |
| P85037 | S428 | Sugiyama | FOXK1 MNF | PFGPLssRsAPAsPtHPGLMsPRsGGLQtPECLsREGsPIP |
| P85037 | T422 | Sugiyama | FOXK1 MNF | VSCFRtPFGPLssRsAPAsPtHPGLMsPRsGGLQtPECLsR |
| Q00534 | S138 | Sugiyama | CDK6 CDKN6 | PTETIKDMMFQLLRGLDFLHsHRVVHRDLKPQNILVTSSGQ |
| Q00534 | S312 | Sugiyama | CDK6 CDKN6 | ysALSHPyFQDLERCKENLDsHLPPsQNtsELNtA______ |
| Q00534 | S317 | Sugiyama | CDK6 CDKN6 | HPyFQDLERCKENLDsHLPPsQNtsELNtA___________ |
| Q00534 | S321 | Sugiyama | CDK6 CDKN6 | QDLERCKENLDsHLPPsQNtsELNtA_______________ |
| Q00534 | S57 | Sugiyama | CDK6 CDKN6 | GRFVALKRVRVQtGEEGMPLsTIREVAVLRHLEtFEHPNVV |
| Q00534 | T267 | Sugiyama | CDK6 CDKN6 | VALPRQAFHSKSAQPIEKFVtDIDELGKDLLLKCLtFNPAK |
| Q00534 | T282 | Sugiyama | CDK6 CDKN6 | IEKFVtDIDELGKDLLLKCLtFNPAKRIsAysALSHPyFQD |
| Q00534 | T325 | Sugiyama | CDK6 CDKN6 | RCKENLDsHLPPsQNtsELNtA___________________ |
| Q00534 | T49 | Sugiyama | CDK6 CDKN6 | KARDLKNGGRFVALKRVRVQtGEEGMPLsTIREVAVLRHLE |
| Q00534 | T70 | Sugiyama | CDK6 CDKN6 | GEEGMPLsTIREVAVLRHLEtFEHPNVVRLFDVCTVSRTDR |
| Q00534 | Y13 | Sugiyama | CDK6 CDKN6 | ________MEKDGLCRADQQyECVAEIGEGAyGKVFKARDL |
| Q00534 | Y24 | Sugiyama | CDK6 CDKN6 | DGLCRADQQyECVAEIGEGAyGKVFKARDLKNGGRFVALKR |
| Q01105 | S166 | Sugiyama | SET | yFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQT |
| Q01196 | S21 | SIGNOR | RUNX1 AML1 CBFA2 | MRIPVDASTSRRFtPPstALsPGKMsEALPLGAPDAGAALA |
| Q01196 | S249 | SIGNOR | RUNX1 AML1 CBFA2 | stAFNPQPQSQMQDTRQIQPsPPWsyDQsyQyLGSIAsPsV |
| Q01196 | S266 | SIGNOR | RUNX1 AML1 CBFA2 | IQPsPPWsyDQsyQyLGSIAsPsVHPAtPIsPGRASGMTTL |
| Q01196 | S276 | SIGNOR | RUNX1 AML1 CBFA2 | QsyQyLGSIAsPsVHPAtPIsPGRASGMTTLSAELSSRLsT |
| Q01196 | S397 | SIGNOR | RUNX1 AML1 CBFA2 | HLYYGASAGSYQFSMVGGERsPPRILPPCTNASTGSALLNP |
| Q01196 | T273 | SIGNOR | RUNX1 AML1 CBFA2 | syDQsyQyLGSIAsPsVHPAtPIsPGRASGMTTLSAELSSR |
| Q01813 | S679 | SIGNOR | PFKP PFKF | KGVFDCRKNVLGHMQQGGAPsPFDRNFGTKISARAMEWITA |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q05639 | T261 | Sugiyama | EEF1A2 EEF1AL STN | PTDKPLRLPLQDVyKIGGIGtVPVGRVETGILRPGMVVTFA |
| Q06830 | T90 | SIGNOR | PRDX1 PAGA PAGB TDPX2 | NCQVIGASVDSHFCHLAWVNtPKKQGGLGPMNIPLVSDPKR |
| Q07020 | T85 | Sugiyama | RPL18 | RMIRKMKLPGRENKtAVVVGtItDDVRVQEVPKLKVCALRV |
| Q08050 | S451 | EPSD|PSP | FOXM1 FKHL16 HFH11 MPP2 WIN | APLSSAGPGKEEKLLFGEGFsPLLPVQTIKEEEIQPGEEMP |
| Q08050 | S489 | EPSD|PSP | FOXM1 FKHL16 HFH11 MPP2 WIN | EMPHLARPIKVEsPPLEEWPsPAPSFKEEssHsWEDssQsP |
| Q08050 | S508 | EPSD|PSP | FOXM1 FKHL16 HFH11 MPP2 WIN | PsPAPSFKEEssHsWEDssQsPtPRPKKSYSGLRsPTRCVS |
| Q08050 | S522 | EPSD|PSP | FOXM1 FKHL16 HFH11 MPP2 WIN | WEDssQsPtPRPKKSYSGLRsPTRCVSEMLVIQHRERRERS |
| Q08050 | S704 | EPSD|PSP | FOXM1 FKHL16 HFH11 MPP2 WIN | LIsVPFGNssPsDIDVPKPGsPEPQVsGLAANRsLtEGLVL |
| Q08050 | T510 | EPSD|PSP | FOXM1 FKHL16 HFH11 MPP2 WIN | PAPSFKEEssHsWEDssQsPtPRPKKSYSGLRsPTRCVSEM |
| Q08050 | T600 | EPSD|PSP | FOXM1 FKHL16 HFH11 MPP2 WIN | DSSDPASQLSYSQEVGGPFKtPIKETLPISStPsKSVLPRt |
| Q08050 | T611 | EPSD|PSP | FOXM1 FKHL16 HFH11 MPP2 WIN | SQEVGGPFKtPIKETLPISStPsKSVLPRtPEsWRLtPPAK |
| Q08050 | T620 | EPSD|PSP | FOXM1 FKHL16 HFH11 MPP2 WIN | tPIKETLPISStPsKSVLPRtPEsWRLtPPAKVGGLDFsPV |
| Q08050 | T627 | EPSD|PSP | FOXM1 FKHL16 HFH11 MPP2 WIN | PISStPsKSVLPRtPEsWRLtPPAKVGGLDFsPVQTSQGAS |
| Q08999 | S1035 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | RBL2 RB2 | KQIKTFAMKYSQANMDAPPLsPYPFVRtGsPRRIQLSQNHP |
| Q08999 | S672 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | RBL2 RB2 | DTGGLGRsItsPTtLyDRYssPPAStTRRRLFVENDsPsDG |
| Q08999 | T401 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | RBL2 RB2 | VQMKNILQQHFDKSKALRIStPLTGVRyIKENsPCVtPVST |
| Q08AD1 | S1319 | Sugiyama | CAMSAP2 CAMSAP1L1 KIAA1078 | NEsVHsGKRtPRsEsVEGFLsPsRCGsRNGEKDWENAstts |
| Q13200 | S16 | Sugiyama | PSMD2 TRAP2 | _____MEEGGRDKAPVQPQQsPAAAPGGtDEKPsGKERRDA |
| Q13242 | S211 | Sugiyama | SRSF9 SFRS9 SRP30C | GYsRsRSGsRGRDsPyQsRGsPHyFsPFRPy__________ |
| Q13242 | S216 | Sugiyama | SRSF9 SFRS9 SRP30C | RSGsRGRDsPyQsRGsPHyFsPFRPy_______________ |
| Q13283 | S231 | Sugiyama | G3BP1 G3BP | QEEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsW |
| Q13283 | S232 | Sugiyama | G3BP1 G3BP | EEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsWA |
| Q13283 | T241 | Sugiyama | G3BP1 G3BP | ETAPEDAQKsssPAPADIAQtVQEDLRtFsWAsVtsKNLPP |
| Q13428 | T1014 | Sugiyama | TCOF1 | ARssssEsEDEDVIPAtQCLtPGIRTNVVTMPTAHPRIAPK |
| Q13573 | S224 | Sugiyama | SNW1 SKIIP SKIP | KDPMEPPRFKINKKIPRGPPsPPAPVMHsPsRKMTVKEQQE |
| Q13573 | S232 | Sugiyama | SNW1 SKIIP SKIP | FKINKKIPRGPPsPPAPVMHsPsRKMTVKEQQEWKIPPCIS |
| Q14157 | S416 | Sugiyama | UBAP2L KIAA0144 NICE4 | tQsPsLVQYDLKNPsDsAVHsPFtKRQAFtPsstMMEVFLQ |
| Q14568 | S53 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | IINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDSG |
| Q14847 | T104 | Sugiyama | LASP1 MLN50 | VRYKEEFEKNKGKGFsVVADtPELQRIKKTQDQIsNIKyHE |
| Q14980 | S1757 | Sugiyama | NUMA1 NMP22 NUMA | ITSKLPRtQPDGtsVPGEPAsPIsQRLPPKVEsLEsLyFtP |
| Q15154 | S69 | Sugiyama | PCM1 | KKKFGVESDKRVTNDISPESsPGVGRRRTKTPHTFPHSRYM |
| Q15293 | T76 | Sugiyama | RCN1 RCN | FQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVDRIDNDGD |
| Q15642 | T302 | Sugiyama | TRIP10 CIP4 STOT STP | VEFEDFsQPMNRAPsDssLGtPsDGRPELRGPGRSRTKRWP |
| Q15717 | S202 | PSP | ELAVL1 HUR | KFAANPNQNKNVALLsQLyHsPARRFGGPVHHQAQRFRFsP |
| Q16204 | S244 | Sugiyama | CCDC6 D10S170 TST1 | LEAEKRILQEKLDQPVsAPPsPRDIsMEIDsPENMMRHIRF |
| Q16875 | S467 | PSP | PFKFB3 | EDAKKGPNPLMRRNsVtPLAsPEPtKKPRINsFEEHVASTS |
| Q16875 | T463 | PSP | PFKFB3 | RERSEDAKKGPNPLMRRNsVtPLAsPEPtKKPRINsFEEHV |
| Q53EL6 | S94 | Sugiyama | PDCD4 H731 | GDsVsDsGsDALRSGLtVPtsPKGRLLDRRSRSGKGRGLPK |
| Q562R1 | T107 | Sugiyama | ACTBL2 | WYHTFYNELRVAPDEHPILLtEAPLNPKINREKMTQIMFEA |
| Q5T4S7 | S178 | Sugiyama | UBR4 KIAA0462 KIAA1307 RBAF600 | AKLPQTVKTLSDVEDQKELAsPVsPELRQKEVQMNFLNQLT |
| Q5T4S7 | S181 | Sugiyama | UBR4 KIAA0462 KIAA1307 RBAF600 | PQTVKTLSDVEDQKELAsPVsPELRQKEVQMNFLNQLTSVF |
| Q5VTE0 | T261 | Sugiyama | EEF1A1P5 EEF1AL3 | PTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKPGMVVtFA |
| Q6P1L8 | S49 | Sugiyama | MRPL14 MRPL32 RPML32 | LSAIQKMTRVRVVDNSALGNsPyHRAPRCIHVYKKNGVGKV |
| Q6PKG0 | S774 | Sugiyama | LARP1 KIAA0731 LARP | LFGAPEPstIARsLPttVPEsPNyRNtRtPRtPRtPQLKDS |
| Q6XUX3 | S483 | Sugiyama | DSTYK KIAA0472 RIP5 RIPK5 SGK496 HDCMD38P | QIQELIISRLNQAVANKLISsVDyLRESFVGtLERCLQSLE |
| Q6XUX3 | T494 | Sugiyama | DSTYK KIAA0472 RIP5 RIPK5 SGK496 HDCMD38P | QAVANKLISsVDyLRESFVGtLERCLQSLEKSQDVSVHITS |
| Q6XUX3 | Y486 | Sugiyama | DSTYK KIAA0472 RIP5 RIPK5 SGK496 HDCMD38P | ELIISRLNQAVANKLISsVDyLRESFVGtLERCLQSLEKSQ |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q71U36 | Y83 | Sugiyama | TUBA1A TUBA3 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q7L2J0 | S216 | Sugiyama | MEPCE BCDIN3 | NLNSLLDEEVSRtLNAEtPKssPLPAKGRDPVEILIPKDIt |
| Q7L2J0 | T213 | Sugiyama | MEPCE BCDIN3 | DPLNLNSLLDEEVSRtLNAEtPKssPLPAKGRDPVEILIPK |
| Q7Z417 | S692 | Sugiyama | NUFIP2 KIAA1321 PIG1 | IWNLQKQDPKRIItyNEAMDsPDQ_________________ |
| Q8IZ21 | S118 | Sugiyama | PHACTR4 PRO2963 | PSDAMLKNGHTTPIGNARsssPVQVEEEPVRLAsLRKAIPE |
| Q8N556 | S265 | Sugiyama | AFAP1 AFAP | KEAYSGCSGPVDSECPPPPssPVHKAELEKKLssERPssDG |
| Q8N556 | S668 | Sugiyama | AFAP1 AFAP | AGGVTLGLAIEPKsGtssPQsPVFRHRtLENsPIssCDtsD |
| Q8NBJ5 | S612 | Sugiyama | COLGALT1 GLT25D1 PSEC0241 | QKMREQQALSREAKNsDVLQsPLDsAARDEL__________ |
| Q8WXI9 | S135 | Sugiyama | GATAD2B KIAA1150 | ERGRLtPsPDIIVLsDNEAssPRsSsRMEERLKAANLEMFK |
| Q8WXI9 | T120 | Sugiyama | GATAD2B KIAA1150 | INDEPVDMSARRsEPERGRLtPsPDIIVLsDNEAssPRsSs |
| Q92879 | S302 | EPSD|PSP | CELF1 BRUNOL2 CUGBP CUGBP1 NAB50 | NALTTSSSPLSVLTSSGSsPsSSSSNSVNPIASLGALQTLA |
| Q96B36 | S212 | Sugiyama | AKT1S1 PRAS40 | GFKEKRtEARssDEENGPPssPDLDRIAAsMRALVLREAED |
| Q96C19 | S74 | Sugiyama | EFHD2 SWS1 | ELSAKLLRRADLNQGIGEPQsPsRRVFNPytEFKEFSRKQI |
| Q96C90 | S32 | Sugiyama | PPP1R14B PLCB3N PNG | LAAPAPGPGsGGPGPRVyFQsPPGAAGEGPGGADDEGPVRR |
| Q96KS0 | S130 | EPSD|PSP | EGLN2 EIT6 | QGARPEAPKRKWAEDGGDAPsPsKRPWARQENQEAEREGGM |
| Q96MH2 | S76 | Sugiyama | HEXIM2 L3 | EDLAGAVGGLGWNsRsPRtQsPGGCsAEAVLARKKHRRRPS |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | Y83 | Sugiyama | TUBA1C TUBA6 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q9BX68 | T47 | Sugiyama | HINT2 | QVRGAAGVTDGNEVAKAQQAtPGGAAPtIFsRILDKsLPAD |
| Q9C0C2 | S1103 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | KRGWVGEFSLSVGPQREAAFsPGQQDWsRDFCIEASERsyQ |
| Q9GZM8 | T245 | SIGNOR | NDEL1 EOPA MITAP1 NUDEL | TENTFPsPKAIPNGFGTsPLtPSARIsALNIVGDLLRKVGA |
| Q9H1E3 | S214 | Sugiyama | NUCKS1 NUCKS JC7 | AsKAsKEKtPsPKEEDEEPEsPPEKKtstsPPPEKsGDEGs |
| Q9H3K6 | T76 | Sugiyama | BOLA2 BOLA2A My016; BOLA2B | VNACLAEELPHIHAFEQKTLtPDQWARERQK__________ |
| Q9H4A3 | S1261 | Sugiyama | WNK1 HSN2 KDP KIAA0344 PRKWNK1 | GIPTSSLTQVVHSAGRRFIVsPVPEsRLRESKVFPSEITDT |
| Q9H773 | S85 | Sugiyama | DCTPP1 XTP3TPA CDA03 | GELAELFQWKTDGEPGPQGWsPRERAALQEELSDVLIYLVA |
| Q9HAP6 | S115 | Sugiyama | LIN7B MALS2 VELI2 UNQ3116/PRO10200 | ELPKTDEGLGFNIMGGKEQNsPIyIsRVIPGGVADRHGGLK |
| Q9NS64 | S98 | PSP | RPRM | CNLLIKSEGMINFLVKDRRPsKEVEAVVVGPY_________ |
| Q9NUP9 | S115 | Sugiyama | LIN7C MALS3 VELI3 | ELPKTEEGLGFNIMGGKEQNsPIyIsRIIPGGIADRHGGLK |
| Q9NYB0 | S203 | Sugiyama | TERF2IP DRIP5 RAP1 PP8000 | RYLKHLRGQEHKyLLGDAPVsPssQKLKRKAEEDPEAADsG |
| Q9NZB2 | T991 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | PLQVVSVGGPARGRPRGVIstPVIRTFGRGGRYYGRGYKNQ |
| Q9NZT2 | S378 | Sugiyama | OGFR | LERsQGDEAGGHGEDRPEPLsPKEsKKRKLELSRREQPPTE |
| Q9UKV3 | S388 | Sugiyama | ACIN1 ACINUS KIAA0670 | EEEEREIKssQGLKEKsKsPsPPRLtEDRKKAsLVALPEQt |
| Q9UQ35 | S1110 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | SQTsPKGGRsRsssPVtELAsRsPIRQDRGEFsAsPMLKsG |
| Q9UQ35 | S2694 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | RSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQSSs |
| Q9Y2B0 | S127 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | RVVGRNGEssELDLQGIRIDsDISGtLKFACEsIVEEyEDE |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2V2 | S30 | Sugiyama | CARHSP1 | QPPtHQAsVGLLDtPRsRERsPsPLRGNVVPsPLPtRRtRt |
| Q9Y2V2 | S32 | Sugiyama | CARHSP1 | PtHQAsVGLLDtPRsRERsPsPLRGNVVPsPLPtRRtRtFs |
| Q9Y2V2 | S41 | Sugiyama | CARHSP1 | LDtPRsRERsPsPLRGNVVPsPLPtRRtRtFsAtVRASQGP |
| Q9Y2W1 | S243 | Sugiyama | THRAP3 BCLAF2 TRAP150 | WPDAtyGtGsAsRAsAVsELsPRERsPALKsPLQsVVVRRR |
| Q9Y6G9 | T513 | Sugiyama | DYNC1LI1 DNCLI1 | LDVHAELDRITRKPVtVsPttPtsPtEGEAs__________ |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle, Mitotic | R-HSA-69278 | 9.606486e-10 | 9.017 | 1 | 0 |
| Cell Cycle | R-HSA-1640170 | 6.767508e-10 | 9.170 | 1 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 7.189163e-07 | 6.143 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.129741e-06 | 5.672 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.384486e-06 | 5.623 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.096740e-06 | 5.509 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 4.776629e-06 | 5.321 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 6.124294e-06 | 5.213 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.150857e-05 | 4.939 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.201495e-05 | 4.657 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.515041e-05 | 4.599 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 6.490561e-05 | 4.188 | 0 | 0 |
| S Phase | R-HSA-69242 | 9.352903e-05 | 4.029 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.044104e-04 | 3.981 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.643138e-04 | 3.784 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 1.979010e-04 | 3.704 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 3.719199e-04 | 3.430 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 3.585507e-04 | 3.445 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 3.585507e-04 | 3.445 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 3.269095e-04 | 3.486 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 9.186291e-04 | 3.037 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.038509e-03 | 2.984 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 1.161670e-03 | 2.935 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 1.161670e-03 | 2.935 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.175721e-03 | 2.930 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.224703e-03 | 2.912 | 1 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.328367e-03 | 2.877 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 1.676232e-03 | 2.776 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.713398e-03 | 2.766 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.566744e-03 | 2.805 | 1 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.494416e-03 | 2.826 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.838280e-03 | 2.736 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.817529e-03 | 2.741 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.692475e-03 | 2.771 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 1.678455e-03 | 2.775 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.643900e-03 | 2.784 | 0 | 0 |
| Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells | R-HSA-210746 | 1.781025e-03 | 2.749 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.221946e-03 | 2.653 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.218217e-03 | 2.654 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.346146e-03 | 2.630 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.598456e-03 | 2.585 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 2.945966e-03 | 2.531 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 2.945966e-03 | 2.531 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 3.602326e-03 | 2.443 | 1 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 3.642000e-03 | 2.439 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.798414e-03 | 2.420 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 3.882136e-03 | 2.411 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 4.625676e-03 | 2.335 | 1 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 4.609473e-03 | 2.336 | 0 | 0 |
| M Phase | R-HSA-68886 | 4.813023e-03 | 2.318 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 4.987701e-03 | 2.302 | 1 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 5.795302e-03 | 2.237 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 5.579902e-03 | 2.253 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 5.500623e-03 | 2.260 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 7.037002e-03 | 2.153 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 7.037002e-03 | 2.153 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 7.035818e-03 | 2.153 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 6.526325e-03 | 2.185 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 6.903735e-03 | 2.161 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 7.037002e-03 | 2.153 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 6.808212e-03 | 2.167 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 7.884454e-03 | 2.103 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 8.673503e-03 | 2.062 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 9.009427e-03 | 2.045 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 9.092009e-03 | 2.041 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.000011e-02 | 2.000 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.012631e-02 | 1.995 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 9.914305e-03 | 2.004 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 9.878114e-03 | 2.005 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.030863e-02 | 1.987 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.046460e-02 | 1.980 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 1.066977e-02 | 1.972 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 1.199310e-02 | 1.921 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.312527e-02 | 1.882 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.399067e-02 | 1.854 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.312527e-02 | 1.882 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 1.312527e-02 | 1.882 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 1.312527e-02 | 1.882 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.327046e-02 | 1.877 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.456828e-02 | 1.837 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.447259e-02 | 1.839 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.309450e-02 | 1.883 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.383463e-02 | 1.859 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.402116e-02 | 1.853 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.458505e-02 | 1.836 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 1.458505e-02 | 1.836 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.602200e-02 | 1.795 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.611169e-02 | 1.793 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.636662e-02 | 1.786 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.746176e-02 | 1.758 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.742858e-02 | 1.759 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.808765e-02 | 1.743 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.921011e-02 | 1.716 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.921011e-02 | 1.716 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.921011e-02 | 1.716 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.006331e-02 | 1.698 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.977650e-02 | 1.704 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.977650e-02 | 1.704 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.890464e-02 | 1.723 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.024141e-02 | 1.694 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.168854e-02 | 1.664 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 2.455340e-02 | 1.610 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 2.455340e-02 | 1.610 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 2.316021e-02 | 1.635 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.435172e-02 | 1.613 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.523751e-02 | 1.598 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.321388e-02 | 1.634 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.647193e-02 | 1.577 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.698775e-02 | 1.569 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.698775e-02 | 1.569 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.698775e-02 | 1.569 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 2.760109e-02 | 1.559 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 3.139533e-02 | 1.503 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 3.139533e-02 | 1.503 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 2.877496e-02 | 1.541 | 1 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 2.877496e-02 | 1.541 | 1 | 1 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.953876e-02 | 1.530 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.990939e-02 | 1.524 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 3.143280e-02 | 1.503 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 3.239873e-02 | 1.489 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.239873e-02 | 1.489 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 3.245707e-02 | 1.489 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 3.542333e-02 | 1.451 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.575754e-02 | 1.447 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 3.912637e-02 | 1.408 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 3.979093e-02 | 1.400 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 3.979093e-02 | 1.400 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 3.979093e-02 | 1.400 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 3.979093e-02 | 1.400 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 3.979093e-02 | 1.400 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 3.911733e-02 | 1.408 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 4.019989e-02 | 1.396 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 4.019989e-02 | 1.396 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 4.217215e-02 | 1.375 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 4.268247e-02 | 1.370 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 4.379757e-02 | 1.359 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 4.379757e-02 | 1.359 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 4.399399e-02 | 1.357 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 4.507575e-02 | 1.346 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.507575e-02 | 1.346 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 4.522481e-02 | 1.345 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 4.570957e-02 | 1.340 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 5.301234e-02 | 1.276 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 5.077407e-02 | 1.294 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 5.077407e-02 | 1.294 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 4.793832e-02 | 1.319 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 5.327618e-02 | 1.273 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 5.354339e-02 | 1.271 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 5.435869e-02 | 1.265 | 0 | 0 |
| Deletions in the AXIN1 gene destabilize the destruction complex | R-HSA-5467345 | 5.435869e-02 | 1.265 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 5.435869e-02 | 1.265 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 5.918140e-02 | 1.228 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 6.182248e-02 | 1.209 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 6.182248e-02 | 1.209 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 6.182248e-02 | 1.209 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 6.182248e-02 | 1.209 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 5.877660e-02 | 1.231 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 5.877660e-02 | 1.231 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 5.423566e-02 | 1.266 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 5.794406e-02 | 1.237 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 6.182248e-02 | 1.209 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 5.612727e-02 | 1.251 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.508021e-02 | 1.259 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 5.994787e-02 | 1.222 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 5.918140e-02 | 1.228 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 5.975066e-02 | 1.224 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 6.429134e-02 | 1.192 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.662315e-02 | 1.176 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 6.680347e-02 | 1.175 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 7.457545e-02 | 1.127 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 7.457545e-02 | 1.127 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 7.457545e-02 | 1.127 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 7.008624e-02 | 1.154 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 7.008624e-02 | 1.154 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 7.927795e-02 | 1.101 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 7.927795e-02 | 1.101 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 7.615909e-02 | 1.118 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 7.615909e-02 | 1.118 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 7.008624e-02 | 1.154 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 7.485198e-02 | 1.126 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 7.126460e-02 | 1.147 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 7.457545e-02 | 1.127 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 7.126460e-02 | 1.147 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 7.485198e-02 | 1.126 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 7.485198e-02 | 1.126 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 7.126460e-02 | 1.147 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 7.776227e-02 | 1.109 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 7.615909e-02 | 1.118 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 7.008624e-02 | 1.154 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.388700e-02 | 1.131 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 7.388700e-02 | 1.131 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 8.040651e-02 | 1.095 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 8.130982e-02 | 1.090 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 8.130982e-02 | 1.090 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.130982e-02 | 1.090 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 8.250691e-02 | 1.084 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 8.537109e-02 | 1.069 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 8.537109e-02 | 1.069 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 8.537109e-02 | 1.069 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.057656e-01 | 0.976 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.057656e-01 | 0.976 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.057656e-01 | 0.976 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.057656e-01 | 0.976 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.057656e-01 | 0.976 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 1.057656e-01 | 0.976 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.057656e-01 | 0.976 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 1.057656e-01 | 0.976 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.057656e-01 | 0.976 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 9.107650e-02 | 1.041 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 9.192698e-02 | 1.037 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 9.192698e-02 | 1.037 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 1.030831e-01 | 0.987 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.120905e-02 | 1.040 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 9.476158e-02 | 1.023 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 8.831443e-02 | 1.054 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.874707e-02 | 1.005 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.874707e-02 | 1.005 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.874707e-02 | 1.005 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 9.302767e-02 | 1.031 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 9.107650e-02 | 1.041 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.029418e-01 | 0.987 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 9.192698e-02 | 1.037 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.054351e-01 | 0.977 | 1 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 9.793854e-02 | 1.009 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 9.793854e-02 | 1.009 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 9.721478e-02 | 1.012 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 9.192698e-02 | 1.037 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.031593e-01 | 0.986 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 1.066734e-01 | 0.972 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 1.066734e-01 | 0.972 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.075004e-01 | 0.969 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 1.085190e-01 | 0.964 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 1.085190e-01 | 0.964 | 0 | 0 |
| Nef mediated downregulation of CD28 cell surface expression | R-HSA-164939 | 1.543809e-01 | 0.811 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5619101 | 1.543809e-01 | 0.811 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 1.543809e-01 | 0.811 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5660686 | 1.543809e-01 | 0.811 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 2.003560e-01 | 0.698 | 0 | 0 |
| Defective OPLAH causes OPLAHD | R-HSA-5578998 | 2.003560e-01 | 0.698 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 2.003560e-01 | 0.698 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 2.438341e-01 | 0.613 | 0 | 0 |
| Defective DPM2 causes DPM2-CDG | R-HSA-4719377 | 2.438341e-01 | 0.613 | 0 | 0 |
| Defective DPM1 causes DPM1-CDG | R-HSA-4717374 | 2.438341e-01 | 0.613 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 2.438341e-01 | 0.613 | 0 | 0 |
| Defective DPM3 causes DPM3-CDG | R-HSA-4719360 | 2.438341e-01 | 0.613 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 1.267521e-01 | 0.897 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.456386e-01 | 0.837 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.849507e-01 | 0.545 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.849507e-01 | 0.545 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 2.849507e-01 | 0.545 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 2.849507e-01 | 0.545 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 2.849507e-01 | 0.545 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 2.849507e-01 | 0.545 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 1.650537e-01 | 0.782 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.650537e-01 | 0.782 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 1.650537e-01 | 0.782 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.147440e-01 | 0.940 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 1.147440e-01 | 0.940 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.848843e-01 | 0.733 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.848843e-01 | 0.733 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.848843e-01 | 0.733 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.848843e-01 | 0.733 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 3.238339e-01 | 0.490 | 0 | 0 |
| IRS activation | R-HSA-74713 | 3.238339e-01 | 0.490 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 3.238339e-01 | 0.490 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 3.238339e-01 | 0.490 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.268745e-01 | 0.897 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 2.050282e-01 | 0.688 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.050282e-01 | 0.688 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 1.394389e-01 | 0.856 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 1.524014e-01 | 0.817 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 2.253926e-01 | 0.647 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 2.253926e-01 | 0.647 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.253926e-01 | 0.647 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 2.253926e-01 | 0.647 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.253926e-01 | 0.647 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.253926e-01 | 0.647 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.253926e-01 | 0.647 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.253926e-01 | 0.647 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 3.606049e-01 | 0.443 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 1.657262e-01 | 0.781 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 1.657262e-01 | 0.781 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 1.657262e-01 | 0.781 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 1.657262e-01 | 0.781 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 2.458943e-01 | 0.609 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 2.458943e-01 | 0.609 | 1 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 2.458943e-01 | 0.609 | 1 | 1 |
| Lagging Strand Synthesis | R-HSA-69186 | 1.793777e-01 | 0.746 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 1.933209e-01 | 0.714 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 2.664583e-01 | 0.574 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 3.953784e-01 | 0.403 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 3.953784e-01 | 0.403 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 3.953784e-01 | 0.403 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 3.953784e-01 | 0.403 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.182157e-01 | 0.927 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 1.261114e-01 | 0.899 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 2.870173e-01 | 0.542 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 2.870173e-01 | 0.542 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 2.870173e-01 | 0.542 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.870173e-01 | 0.542 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 2.870173e-01 | 0.542 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 2.870173e-01 | 0.542 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 1.426008e-01 | 0.846 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 1.426008e-01 | 0.846 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 1.426008e-01 | 0.846 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 4.282627e-01 | 0.368 | 0 | 0 |
| Glycoprotein hormones | R-HSA-209822 | 4.282627e-01 | 0.368 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 4.282627e-01 | 0.368 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 1.599666e-01 | 0.796 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.374348e-01 | 0.862 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 2.513368e-01 | 0.600 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 1.447985e-01 | 0.839 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 1.781384e-01 | 0.749 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 1.523383e-01 | 0.817 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 1.523383e-01 | 0.817 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 2.217956e-01 | 0.654 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 2.217956e-01 | 0.654 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.875032e-01 | 0.727 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 4.593604e-01 | 0.338 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 4.593604e-01 | 0.338 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 4.593604e-01 | 0.338 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 4.593604e-01 | 0.338 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 4.593604e-01 | 0.338 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 3.680947e-01 | 0.434 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 2.009571e-01 | 0.697 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.114455e-01 | 0.507 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 3.114455e-01 | 0.507 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 2.469750e-01 | 0.607 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 2.469750e-01 | 0.607 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 3.878493e-01 | 0.411 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 4.887684e-01 | 0.311 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 4.887684e-01 | 0.311 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.573393e-01 | 0.589 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 2.573393e-01 | 0.589 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 4.073259e-01 | 0.390 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 5.165784e-01 | 0.287 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.303704e-01 | 0.885 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 3.568233e-01 | 0.448 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 3.568233e-01 | 0.448 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 3.568233e-01 | 0.448 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 4.018040e-01 | 0.396 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 4.018040e-01 | 0.396 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 4.018040e-01 | 0.396 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 3.207984e-01 | 0.494 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 4.638258e-01 | 0.334 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 4.638258e-01 | 0.334 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 5.428772e-01 | 0.265 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 4.819463e-01 | 0.317 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 4.819463e-01 | 0.317 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 4.458336e-01 | 0.351 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 4.315760e-01 | 0.365 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 5.170257e-01 | 0.286 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 5.023863e-01 | 0.299 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 5.339632e-01 | 0.272 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 5.160611e-01 | 0.287 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 5.037928e-01 | 0.298 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 5.504888e-01 | 0.259 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 5.504888e-01 | 0.259 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 5.504888e-01 | 0.259 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 5.504888e-01 | 0.259 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 5.269710e-01 | 0.278 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 2.543808e-01 | 0.595 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 2.217956e-01 | 0.654 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 1.657262e-01 | 0.781 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.875032e-01 | 0.727 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 1.342424e-01 | 0.872 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 2.124599e-01 | 0.673 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.669191e-01 | 0.574 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 3.114455e-01 | 0.507 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 3.265880e-01 | 0.486 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 2.165961e-01 | 0.664 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 4.444292e-01 | 0.352 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 2.730020e-01 | 0.564 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.656859e-01 | 0.781 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 2.812462e-01 | 0.551 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 3.265880e-01 | 0.486 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 5.160611e-01 | 0.287 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 1.448561e-01 | 0.839 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.217956e-01 | 0.654 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 4.996836e-01 | 0.301 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.933209e-01 | 0.714 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 2.050282e-01 | 0.688 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.394389e-01 | 0.856 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 2.664583e-01 | 0.574 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 2.075214e-01 | 0.683 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.480191e-01 | 0.830 | 0 | 0 |
| Peptide hormone biosynthesis | R-HSA-209952 | 5.165784e-01 | 0.287 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 5.165784e-01 | 0.287 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 5.047613e-01 | 0.297 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.311150e-01 | 0.882 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 5.253270e-01 | 0.280 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 3.568233e-01 | 0.448 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.301130e-01 | 0.886 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.456386e-01 | 0.837 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 2.849507e-01 | 0.545 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 3.606049e-01 | 0.443 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.075214e-01 | 0.683 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 2.075214e-01 | 0.683 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 4.282627e-01 | 0.368 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.513368e-01 | 0.600 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 2.812462e-01 | 0.551 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 4.593604e-01 | 0.338 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 3.878493e-01 | 0.411 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 3.878493e-01 | 0.411 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 4.887684e-01 | 0.311 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 4.018040e-01 | 0.396 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 2.057919e-01 | 0.687 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 2.057919e-01 | 0.687 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 2.399506e-01 | 0.620 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.824334e-01 | 0.549 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 4.166069e-01 | 0.380 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.311150e-01 | 0.882 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 4.602282e-01 | 0.337 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.511784e-01 | 0.821 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 2.528382e-01 | 0.597 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 1.848843e-01 | 0.733 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 3.238339e-01 | 0.490 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 2.050282e-01 | 0.688 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 3.606049e-01 | 0.443 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 3.067701e-01 | 0.513 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.255490e-01 | 0.647 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 4.264965e-01 | 0.370 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 5.428772e-01 | 0.265 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 3.943780e-01 | 0.404 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 1.842247e-01 | 0.735 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 5.170257e-01 | 0.286 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 5.160611e-01 | 0.287 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.280022e-01 | 0.893 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.114455e-01 | 0.507 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.365614e-01 | 0.626 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.365614e-01 | 0.626 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 4.376922e-01 | 0.359 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 5.339632e-01 | 0.272 | 1 | 1 |
| DNA Replication | R-HSA-69306 | 1.673187e-01 | 0.776 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 3.953784e-01 | 0.403 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.365614e-01 | 0.626 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 3.278860e-01 | 0.484 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.868963e-01 | 0.412 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 5.428772e-01 | 0.265 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 5.269710e-01 | 0.278 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.812462e-01 | 0.551 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 2.101793e-01 | 0.677 | 1 | 1 |
| Chromosome Maintenance | R-HSA-73886 | 1.407673e-01 | 0.851 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 2.783635e-01 | 0.555 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 2.365614e-01 | 0.626 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.489716e-01 | 0.604 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 1.448561e-01 | 0.839 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 4.887684e-01 | 0.311 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 2.890030e-01 | 0.539 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 1.650537e-01 | 0.782 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.732162e-01 | 0.761 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.220627e-01 | 0.913 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 2.003560e-01 | 0.698 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 2.438341e-01 | 0.613 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 2.438341e-01 | 0.613 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.267521e-01 | 0.897 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.456386e-01 | 0.837 | 0 | 0 |
| Alanine metabolism | R-HSA-8964540 | 2.849507e-01 | 0.545 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 2.050282e-01 | 0.688 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 2.050282e-01 | 0.688 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 1.394389e-01 | 0.856 | 0 | 0 |
| Synthesis of dolichyl-phosphate mannose | R-HSA-162699 | 3.606049e-01 | 0.443 | 0 | 0 |
| Sensory perception of salty taste | R-HSA-9730628 | 3.606049e-01 | 0.443 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 3.606049e-01 | 0.443 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.458943e-01 | 0.609 | 0 | 0 |
| Intracellular metabolism of fatty acids regulates insulin secretion | R-HSA-434313 | 3.953784e-01 | 0.403 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 1.551392e-01 | 0.809 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 4.282627e-01 | 0.368 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 4.282627e-01 | 0.368 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 4.282627e-01 | 0.368 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.781384e-01 | 0.749 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 3.114455e-01 | 0.507 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 4.887684e-01 | 0.311 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.863249e-01 | 0.730 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 5.165784e-01 | 0.287 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 5.165784e-01 | 0.287 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 4.018040e-01 | 0.396 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 5.428772e-01 | 0.265 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 3.635253e-01 | 0.439 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 4.602282e-01 | 0.337 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 5.170257e-01 | 0.286 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.383610e-01 | 0.269 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 5.410573e-01 | 0.267 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 4.758045e-01 | 0.323 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.407673e-01 | 0.851 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 2.664583e-01 | 0.574 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 4.885159e-01 | 0.311 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 5.427901e-01 | 0.265 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 2.253926e-01 | 0.647 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 1.793777e-01 | 0.746 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.600489e-01 | 0.796 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.996836e-01 | 0.301 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.255490e-01 | 0.647 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 2.260474e-01 | 0.646 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.496721e-01 | 0.603 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 1.268745e-01 | 0.897 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 4.920174e-01 | 0.308 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.523383e-01 | 0.817 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 3.568233e-01 | 0.448 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 3.238339e-01 | 0.490 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.878493e-01 | 0.411 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 4.073259e-01 | 0.390 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 5.165784e-01 | 0.287 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 5.170257e-01 | 0.286 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.842501e-01 | 0.735 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 1.657262e-01 | 0.781 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 4.638258e-01 | 0.334 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 1.456386e-01 | 0.837 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 1.268745e-01 | 0.897 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 3.606049e-01 | 0.443 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.606049e-01 | 0.443 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 2.075214e-01 | 0.683 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.870173e-01 | 0.542 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 3.480946e-01 | 0.458 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 4.593604e-01 | 0.338 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 3.719014e-01 | 0.430 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 5.165784e-01 | 0.287 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.919357e-01 | 0.535 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 5.081607e-01 | 0.294 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.506776e-01 | 0.822 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 3.111252e-01 | 0.507 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 3.430772e-01 | 0.465 | 0 | 0 |
| Hormone ligand-binding receptors | R-HSA-375281 | 5.428772e-01 | 0.265 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.315760e-01 | 0.365 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.255490e-01 | 0.647 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.893384e-01 | 0.410 | 1 | 1 |
| Cellular responses to stress | R-HSA-2262752 | 4.689166e-01 | 0.329 | 1 | 0 |
| Mismatch Repair | R-HSA-5358508 | 1.394389e-01 | 0.856 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.960357e-01 | 0.708 | 1 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 2.018847e-01 | 0.695 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 4.943476e-01 | 0.306 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 1.267521e-01 | 0.897 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 1.147440e-01 | 0.940 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 3.238339e-01 | 0.490 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 1.793777e-01 | 0.746 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 3.953784e-01 | 0.403 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.764799e-01 | 0.753 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 4.282627e-01 | 0.368 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 4.593604e-01 | 0.338 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 4.593604e-01 | 0.338 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.114455e-01 | 0.507 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 4.887684e-01 | 0.311 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 4.887684e-01 | 0.311 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.557642e-01 | 0.808 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 4.264965e-01 | 0.370 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 5.165784e-01 | 0.287 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 5.165784e-01 | 0.287 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 3.430772e-01 | 0.465 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 5.428772e-01 | 0.265 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 3.171828e-01 | 0.499 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 4.996836e-01 | 0.301 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 4.732850e-01 | 0.325 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 5.504888e-01 | 0.259 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.265880e-01 | 0.486 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 5.445131e-01 | 0.264 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 4.027719e-01 | 0.395 | 1 | 0 |
| Base Excision Repair | R-HSA-73884 | 3.189493e-01 | 0.496 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.185789e-01 | 0.660 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 5.504888e-01 | 0.259 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.568233e-01 | 0.448 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.456386e-01 | 0.837 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 3.606049e-01 | 0.443 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 2.963232e-01 | 0.528 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 4.819463e-01 | 0.317 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 3.712378e-01 | 0.430 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 5.170257e-01 | 0.286 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 5.317354e-01 | 0.274 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 4.849871e-01 | 0.314 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.009571e-01 | 0.697 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 4.264965e-01 | 0.370 | 0 | 0 |
| Kinesins | R-HSA-983189 | 3.321778e-01 | 0.479 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 4.264965e-01 | 0.370 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 4.025118e-01 | 0.395 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 3.995213e-01 | 0.398 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.719014e-01 | 0.430 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 4.018040e-01 | 0.396 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.516426e-01 | 0.345 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 1.759592e-01 | 0.755 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 4.096058e-01 | 0.388 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.261114e-01 | 0.899 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 2.812462e-01 | 0.551 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 3.568380e-01 | 0.448 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 3.540001e-01 | 0.451 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 2.849507e-01 | 0.545 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 3.238339e-01 | 0.490 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 3.238339e-01 | 0.490 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 2.253926e-01 | 0.647 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 2.870173e-01 | 0.542 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.342424e-01 | 0.872 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 1.764799e-01 | 0.753 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 4.282627e-01 | 0.368 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 4.282627e-01 | 0.368 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 4.593604e-01 | 0.338 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 5.428772e-01 | 0.265 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 5.339632e-01 | 0.272 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 3.554619e-01 | 0.449 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 3.194935e-01 | 0.496 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 3.823979e-01 | 0.417 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.305880e-01 | 0.884 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 5.502386e-01 | 0.259 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.814367e-01 | 0.551 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.814367e-01 | 0.551 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.656859e-01 | 0.781 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 5.170257e-01 | 0.286 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.647957e-01 | 0.783 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.617194e-01 | 0.791 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 4.312884e-01 | 0.365 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 2.783635e-01 | 0.555 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.650537e-01 | 0.782 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 4.887684e-01 | 0.311 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.730020e-01 | 0.564 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 3.321778e-01 | 0.479 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 5.339632e-01 | 0.272 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 5.427901e-01 | 0.265 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 1.268745e-01 | 0.897 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 3.606049e-01 | 0.443 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.664583e-01 | 0.574 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 3.953784e-01 | 0.403 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 2.870173e-01 | 0.542 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.875032e-01 | 0.727 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 4.887684e-01 | 0.311 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 4.887684e-01 | 0.311 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 5.428772e-01 | 0.265 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 5.428772e-01 | 0.265 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.090035e-01 | 0.680 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 5.383610e-01 | 0.269 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.133983e-01 | 0.945 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.664583e-01 | 0.574 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.182157e-01 | 0.927 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.219458e-01 | 0.654 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 3.075110e-01 | 0.512 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 3.680947e-01 | 0.434 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 5.165784e-01 | 0.287 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 4.068320e-01 | 0.391 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.068320e-01 | 0.391 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 4.819463e-01 | 0.317 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 3.192411e-01 | 0.496 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 4.245372e-01 | 0.372 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 4.453367e-01 | 0.351 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 4.996836e-01 | 0.301 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.370952e-01 | 0.625 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 3.606049e-01 | 0.443 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 5.428772e-01 | 0.265 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 5.269710e-01 | 0.278 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.593697e-01 | 0.586 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 2.027982e-01 | 0.693 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 3.238339e-01 | 0.490 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 1.933209e-01 | 0.714 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 4.282627e-01 | 0.368 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 4.887684e-01 | 0.311 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 5.165784e-01 | 0.287 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.575591e-01 | 0.589 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.513368e-01 | 0.600 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 5.354691e-01 | 0.271 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 4.887684e-01 | 0.311 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 5.165784e-01 | 0.287 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 2.458943e-01 | 0.609 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 1.301130e-01 | 0.886 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 3.480946e-01 | 0.458 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 4.744596e-01 | 0.324 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.496107e-01 | 0.260 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 4.996836e-01 | 0.301 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 5.504888e-01 | 0.259 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 5.504888e-01 | 0.259 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 2.664583e-01 | 0.574 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 3.878493e-01 | 0.411 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 4.819463e-01 | 0.317 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 3.238339e-01 | 0.490 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 3.680947e-01 | 0.434 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 4.312884e-01 | 0.365 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 5.504888e-01 | 0.259 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 4.018040e-01 | 0.396 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 5.037928e-01 | 0.298 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 5.295317e-01 | 0.276 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 2.812462e-01 | 0.551 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 4.744596e-01 | 0.324 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 5.558294e-01 | 0.255 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 5.558294e-01 | 0.255 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 5.607149e-01 | 0.251 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.607149e-01 | 0.251 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.607149e-01 | 0.251 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 5.607149e-01 | 0.251 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 5.665972e-01 | 0.247 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 5.665972e-01 | 0.247 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 5.665972e-01 | 0.247 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 5.677468e-01 | 0.246 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 5.677468e-01 | 0.246 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 5.677468e-01 | 0.246 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 5.677468e-01 | 0.246 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 5.677468e-01 | 0.246 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 5.677468e-01 | 0.246 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 5.677468e-01 | 0.246 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 5.677468e-01 | 0.246 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 5.677468e-01 | 0.246 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 5.677468e-01 | 0.246 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 5.677468e-01 | 0.246 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 5.677468e-01 | 0.246 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 5.686435e-01 | 0.245 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 5.716686e-01 | 0.243 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 5.716686e-01 | 0.243 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 5.736368e-01 | 0.241 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 5.746882e-01 | 0.241 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 5.749971e-01 | 0.240 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 5.812272e-01 | 0.236 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 5.812272e-01 | 0.236 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 5.822849e-01 | 0.235 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 5.822849e-01 | 0.235 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 5.822849e-01 | 0.235 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 5.822849e-01 | 0.235 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 5.822849e-01 | 0.235 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 5.822849e-01 | 0.235 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 5.822849e-01 | 0.235 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 5.822849e-01 | 0.235 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 5.824677e-01 | 0.235 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 5.824677e-01 | 0.235 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 5.845997e-01 | 0.233 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 5.871224e-01 | 0.231 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 5.912648e-01 | 0.228 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 5.912648e-01 | 0.228 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 5.912648e-01 | 0.228 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 5.912648e-01 | 0.228 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.912648e-01 | 0.228 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 5.935759e-01 | 0.227 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 5.975499e-01 | 0.224 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 5.975499e-01 | 0.224 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 5.975499e-01 | 0.224 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 5.975499e-01 | 0.224 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 6.023767e-01 | 0.220 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 6.035807e-01 | 0.219 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 6.040136e-01 | 0.219 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 6.042941e-01 | 0.219 | 1 | 1 |
| EGFR downregulation | R-HSA-182971 | 6.123918e-01 | 0.213 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 6.135032e-01 | 0.212 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 6.135046e-01 | 0.212 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 6.135046e-01 | 0.212 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 6.135046e-01 | 0.212 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 6.135046e-01 | 0.212 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 6.135046e-01 | 0.212 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 6.135046e-01 | 0.212 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 6.135046e-01 | 0.212 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 6.135046e-01 | 0.212 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 6.135046e-01 | 0.212 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 6.138995e-01 | 0.212 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 6.175537e-01 | 0.209 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 6.281020e-01 | 0.202 | 1 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 6.288756e-01 | 0.201 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 6.307797e-01 | 0.200 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 6.340190e-01 | 0.198 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 6.345356e-01 | 0.198 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 6.345356e-01 | 0.198 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 6.345356e-01 | 0.198 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 6.345356e-01 | 0.198 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 6.345356e-01 | 0.198 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 6.345356e-01 | 0.198 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 6.345356e-01 | 0.198 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 6.405544e-01 | 0.193 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 6.405544e-01 | 0.193 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 6.405544e-01 | 0.193 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 6.408110e-01 | 0.193 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 6.408110e-01 | 0.193 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 6.408110e-01 | 0.193 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 6.408110e-01 | 0.193 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 6.408110e-01 | 0.193 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 6.408110e-01 | 0.193 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 6.434244e-01 | 0.192 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 6.438209e-01 | 0.191 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 6.438209e-01 | 0.191 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 6.438991e-01 | 0.191 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 6.516839e-01 | 0.186 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 6.516839e-01 | 0.186 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 6.516839e-01 | 0.186 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 6.516839e-01 | 0.186 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 6.534486e-01 | 0.185 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 6.543932e-01 | 0.184 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 6.544234e-01 | 0.184 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 6.544234e-01 | 0.184 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 6.544234e-01 | 0.184 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 6.544234e-01 | 0.184 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 6.544234e-01 | 0.184 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 6.544234e-01 | 0.184 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 6.544234e-01 | 0.184 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 6.569972e-01 | 0.182 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 6.611777e-01 | 0.180 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 6.625650e-01 | 0.179 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 6.625650e-01 | 0.179 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 6.629006e-01 | 0.179 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 6.675621e-01 | 0.176 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 6.675621e-01 | 0.176 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 6.675621e-01 | 0.176 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 6.675621e-01 | 0.176 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 6.675621e-01 | 0.176 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 6.704690e-01 | 0.174 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 6.721757e-01 | 0.173 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 6.731974e-01 | 0.172 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 6.732300e-01 | 0.172 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 6.732300e-01 | 0.172 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 6.732300e-01 | 0.172 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 6.732300e-01 | 0.172 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 6.732300e-01 | 0.172 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 6.732300e-01 | 0.172 | 0 | 0 |
| Mineralocorticoid biosynthesis | R-HSA-193993 | 6.732300e-01 | 0.172 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 6.732300e-01 | 0.172 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 6.732300e-01 | 0.172 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 6.770836e-01 | 0.169 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 6.783227e-01 | 0.169 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 6.803225e-01 | 0.167 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 6.803225e-01 | 0.167 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 6.803225e-01 | 0.167 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 6.835811e-01 | 0.165 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 6.910143e-01 | 0.161 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 6.910143e-01 | 0.161 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 6.910143e-01 | 0.161 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 6.910143e-01 | 0.161 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 6.910143e-01 | 0.161 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 6.912846e-01 | 0.160 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 6.912846e-01 | 0.160 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 6.926798e-01 | 0.159 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 6.937168e-01 | 0.159 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 6.937168e-01 | 0.159 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 6.985280e-01 | 0.156 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 7.003040e-01 | 0.155 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 7.046401e-01 | 0.152 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 7.046401e-01 | 0.152 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 7.046401e-01 | 0.152 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 7.078317e-01 | 0.150 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 7.078317e-01 | 0.150 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 7.078317e-01 | 0.150 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 7.078317e-01 | 0.150 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 7.078317e-01 | 0.150 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 7.078317e-01 | 0.150 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 7.078317e-01 | 0.150 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 7.078317e-01 | 0.150 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 7.078317e-01 | 0.150 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 7.078317e-01 | 0.150 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 7.089128e-01 | 0.149 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 7.131809e-01 | 0.147 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 7.206581e-01 | 0.142 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.226476e-01 | 0.141 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 7.226476e-01 | 0.141 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 7.237347e-01 | 0.140 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 7.237347e-01 | 0.140 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 7.237347e-01 | 0.140 | 0 | 0 |
| PKA activation | R-HSA-163615 | 7.237347e-01 | 0.140 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 7.237347e-01 | 0.140 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 7.237347e-01 | 0.140 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 7.237347e-01 | 0.140 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 7.237347e-01 | 0.140 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 7.237347e-01 | 0.140 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 7.237347e-01 | 0.140 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 7.273964e-01 | 0.138 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 7.273964e-01 | 0.138 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 7.279951e-01 | 0.138 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 7.279951e-01 | 0.138 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 7.279951e-01 | 0.138 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 7.284250e-01 | 0.138 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 7.306411e-01 | 0.136 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 7.318046e-01 | 0.136 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 7.330186e-01 | 0.135 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 7.351922e-01 | 0.134 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 7.355440e-01 | 0.133 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 7.382070e-01 | 0.132 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 7.382070e-01 | 0.132 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 7.382070e-01 | 0.132 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 7.382070e-01 | 0.132 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 7.382070e-01 | 0.132 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 7.382070e-01 | 0.132 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 7.382070e-01 | 0.132 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 7.382070e-01 | 0.132 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 7.382070e-01 | 0.132 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 7.382070e-01 | 0.132 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 7.387730e-01 | 0.131 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 7.387730e-01 | 0.131 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 7.387730e-01 | 0.131 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 7.387730e-01 | 0.131 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 7.387730e-01 | 0.131 | 0 | 0 |
| HDL remodeling | R-HSA-8964058 | 7.387730e-01 | 0.131 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 7.387730e-01 | 0.131 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 7.387730e-01 | 0.131 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 7.387730e-01 | 0.131 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 7.395699e-01 | 0.131 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 7.407219e-01 | 0.130 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 7.407219e-01 | 0.130 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 7.486494e-01 | 0.126 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 7.486494e-01 | 0.126 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 7.499032e-01 | 0.125 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 7.499032e-01 | 0.125 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 7.510803e-01 | 0.124 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 7.529936e-01 | 0.123 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 7.529936e-01 | 0.123 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 7.529936e-01 | 0.123 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 7.529936e-01 | 0.123 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 7.529936e-01 | 0.123 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 7.529936e-01 | 0.123 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 7.553431e-01 | 0.122 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 7.559472e-01 | 0.122 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 7.563492e-01 | 0.121 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 7.587316e-01 | 0.120 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 7.587316e-01 | 0.120 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 7.587316e-01 | 0.120 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 7.587316e-01 | 0.120 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 7.608396e-01 | 0.119 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 7.608396e-01 | 0.119 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 7.620836e-01 | 0.118 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 7.624719e-01 | 0.118 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 7.664408e-01 | 0.116 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 7.664408e-01 | 0.116 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 7.664408e-01 | 0.116 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 7.664408e-01 | 0.116 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 7.664408e-01 | 0.116 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 7.664408e-01 | 0.116 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 7.664408e-01 | 0.116 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 7.664408e-01 | 0.116 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 7.664408e-01 | 0.116 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 7.674875e-01 | 0.115 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 7.684620e-01 | 0.114 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 7.684620e-01 | 0.114 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 7.684620e-01 | 0.114 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 7.684620e-01 | 0.114 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 7.684620e-01 | 0.114 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 7.691391e-01 | 0.114 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 7.696288e-01 | 0.114 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 7.714639e-01 | 0.113 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 7.740484e-01 | 0.111 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 7.754986e-01 | 0.110 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 7.766156e-01 | 0.110 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 7.778489e-01 | 0.109 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 7.791567e-01 | 0.108 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 7.791567e-01 | 0.108 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 7.791567e-01 | 0.108 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 7.791567e-01 | 0.108 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 7.791567e-01 | 0.108 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 7.791567e-01 | 0.108 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 7.791567e-01 | 0.108 | 0 | 0 |
| Androgen biosynthesis | R-HSA-193048 | 7.791567e-01 | 0.108 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 7.791567e-01 | 0.108 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 7.791567e-01 | 0.108 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 7.834341e-01 | 0.106 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 7.843739e-01 | 0.105 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 7.869008e-01 | 0.104 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 7.869008e-01 | 0.104 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 7.893498e-01 | 0.103 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 7.893498e-01 | 0.103 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 7.900860e-01 | 0.102 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.911811e-01 | 0.102 | 0 | 0 |
| Reactions specific to the complex N-glycan synthesis pathway | R-HSA-975578 | 7.911811e-01 | 0.102 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 7.911811e-01 | 0.102 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.911811e-01 | 0.102 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.911811e-01 | 0.102 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 7.956265e-01 | 0.099 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 7.956265e-01 | 0.099 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 7.956265e-01 | 0.099 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 7.956265e-01 | 0.099 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 7.956265e-01 | 0.099 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 7.956265e-01 | 0.099 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.995880e-01 | 0.097 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 8.025514e-01 | 0.096 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 8.025514e-01 | 0.096 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 8.025514e-01 | 0.096 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 8.025514e-01 | 0.096 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 8.025514e-01 | 0.096 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 8.028983e-01 | 0.095 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.040345e-01 | 0.095 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 8.052900e-01 | 0.094 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 8.056696e-01 | 0.094 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 8.106788e-01 | 0.091 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 8.121336e-01 | 0.090 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 8.121336e-01 | 0.090 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 8.121336e-01 | 0.090 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 8.133033e-01 | 0.090 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 8.133033e-01 | 0.090 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 8.133033e-01 | 0.090 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.133033e-01 | 0.090 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 8.155582e-01 | 0.089 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 8.169691e-01 | 0.088 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 8.173710e-01 | 0.088 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 8.184534e-01 | 0.087 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 8.188973e-01 | 0.087 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 8.197038e-01 | 0.086 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 8.199325e-01 | 0.086 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.199325e-01 | 0.086 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.209197e-01 | 0.086 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 8.209197e-01 | 0.086 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 8.209197e-01 | 0.086 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 8.234703e-01 | 0.084 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 8.234703e-01 | 0.084 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 8.234703e-01 | 0.084 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 8.234703e-01 | 0.084 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 8.234703e-01 | 0.084 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.234703e-01 | 0.084 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 8.234703e-01 | 0.084 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 8.234703e-01 | 0.084 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 8.246889e-01 | 0.084 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 8.274399e-01 | 0.082 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 8.274399e-01 | 0.082 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 8.330842e-01 | 0.079 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 8.330842e-01 | 0.079 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 8.330842e-01 | 0.079 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 8.330842e-01 | 0.079 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 8.330842e-01 | 0.079 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 8.330842e-01 | 0.079 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 8.330842e-01 | 0.079 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.346643e-01 | 0.078 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 8.416142e-01 | 0.075 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 8.421751e-01 | 0.075 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 8.421751e-01 | 0.075 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 8.421751e-01 | 0.075 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.421751e-01 | 0.075 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 8.421751e-01 | 0.075 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 8.421751e-01 | 0.075 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 8.421751e-01 | 0.075 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 8.478834e-01 | 0.072 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 8.479193e-01 | 0.072 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 8.507714e-01 | 0.070 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 8.507714e-01 | 0.070 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 8.507714e-01 | 0.070 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.507714e-01 | 0.070 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 8.507714e-01 | 0.070 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 8.507714e-01 | 0.070 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.507714e-01 | 0.070 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.547246e-01 | 0.068 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 8.547246e-01 | 0.068 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 8.547246e-01 | 0.068 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 8.554518e-01 | 0.068 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.554607e-01 | 0.068 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 8.580242e-01 | 0.067 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 8.589000e-01 | 0.066 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 8.589000e-01 | 0.066 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 8.589000e-01 | 0.066 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 8.589000e-01 | 0.066 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 8.609016e-01 | 0.065 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 8.609016e-01 | 0.065 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 8.640746e-01 | 0.063 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 8.640746e-01 | 0.063 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.649238e-01 | 0.063 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 8.665862e-01 | 0.062 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 8.665862e-01 | 0.062 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 8.690055e-01 | 0.061 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 8.690055e-01 | 0.061 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 8.725395e-01 | 0.059 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.738542e-01 | 0.059 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 8.738542e-01 | 0.059 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.738542e-01 | 0.059 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.738542e-01 | 0.059 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 8.738645e-01 | 0.059 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 8.761954e-01 | 0.057 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 8.761954e-01 | 0.057 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 8.780162e-01 | 0.056 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 8.780162e-01 | 0.056 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 8.807267e-01 | 0.055 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 8.807267e-01 | 0.055 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 8.807267e-01 | 0.055 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 8.831057e-01 | 0.054 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 8.832750e-01 | 0.054 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 8.872251e-01 | 0.052 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 8.872251e-01 | 0.052 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 8.872251e-01 | 0.052 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 8.874962e-01 | 0.052 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 8.883233e-01 | 0.051 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.883233e-01 | 0.051 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 8.916840e-01 | 0.050 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 8.917387e-01 | 0.050 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 8.931685e-01 | 0.049 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.931685e-01 | 0.049 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.933699e-01 | 0.049 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.933699e-01 | 0.049 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 8.933699e-01 | 0.049 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 8.933699e-01 | 0.049 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 8.943199e-01 | 0.049 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 8.978177e-01 | 0.047 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 8.978177e-01 | 0.047 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 8.978177e-01 | 0.047 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 8.991802e-01 | 0.046 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 8.991802e-01 | 0.046 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 8.991802e-01 | 0.046 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 9.036184e-01 | 0.044 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.046742e-01 | 0.044 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.046742e-01 | 0.044 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.046742e-01 | 0.044 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.065556e-01 | 0.043 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 9.091111e-01 | 0.041 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 9.091111e-01 | 0.041 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.098692e-01 | 0.041 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 9.098692e-01 | 0.041 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.098692e-01 | 0.041 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 9.098692e-01 | 0.041 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.098692e-01 | 0.041 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 9.098692e-01 | 0.041 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 9.098692e-01 | 0.041 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.106578e-01 | 0.041 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.126840e-01 | 0.040 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.143077e-01 | 0.039 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 9.145908e-01 | 0.039 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.147813e-01 | 0.039 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.147813e-01 | 0.039 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.147813e-01 | 0.039 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.147813e-01 | 0.039 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.147813e-01 | 0.039 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.147813e-01 | 0.039 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.147813e-01 | 0.039 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.158847e-01 | 0.038 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.176239e-01 | 0.037 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 9.176239e-01 | 0.037 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.183299e-01 | 0.037 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 9.183609e-01 | 0.037 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.183609e-01 | 0.037 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.192546e-01 | 0.037 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.194261e-01 | 0.036 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.194261e-01 | 0.036 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.194261e-01 | 0.036 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.194261e-01 | 0.036 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.194261e-01 | 0.036 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.194261e-01 | 0.036 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.194261e-01 | 0.036 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.208226e-01 | 0.036 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 9.212117e-01 | 0.036 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 9.219740e-01 | 0.035 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 9.238179e-01 | 0.034 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 9.238179e-01 | 0.034 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 9.238179e-01 | 0.034 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.238179e-01 | 0.034 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.239074e-01 | 0.034 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.254361e-01 | 0.034 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.267031e-01 | 0.033 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.279706e-01 | 0.032 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.279706e-01 | 0.032 | 0 | 0 |
| N-glycan antennae elongation in the medial/trans-Golgi | R-HSA-975576 | 9.279706e-01 | 0.032 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 9.282212e-01 | 0.032 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.297492e-01 | 0.032 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.298129e-01 | 0.032 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.318972e-01 | 0.031 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.318972e-01 | 0.031 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.319300e-01 | 0.031 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 9.319300e-01 | 0.031 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.334556e-01 | 0.030 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.342952e-01 | 0.030 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.351762e-01 | 0.029 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.356099e-01 | 0.029 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.356099e-01 | 0.029 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.356099e-01 | 0.029 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.356099e-01 | 0.029 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.356099e-01 | 0.029 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 9.356099e-01 | 0.029 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 9.356783e-01 | 0.029 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.391204e-01 | 0.027 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.391204e-01 | 0.027 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.424398e-01 | 0.026 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.424398e-01 | 0.026 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.424398e-01 | 0.026 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.424398e-01 | 0.026 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 9.424398e-01 | 0.026 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.425947e-01 | 0.026 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 9.433457e-01 | 0.025 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.448873e-01 | 0.025 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.455784e-01 | 0.024 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.455784e-01 | 0.024 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.456992e-01 | 0.024 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.459012e-01 | 0.024 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 9.470945e-01 | 0.024 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 9.483467e-01 | 0.023 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.485460e-01 | 0.023 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.485460e-01 | 0.023 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 9.485460e-01 | 0.023 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.506866e-01 | 0.022 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 9.512645e-01 | 0.022 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 9.513519e-01 | 0.022 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.513519e-01 | 0.022 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.523660e-01 | 0.021 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.528729e-01 | 0.021 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.529251e-01 | 0.021 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.529251e-01 | 0.021 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.529251e-01 | 0.021 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.529251e-01 | 0.021 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.529251e-01 | 0.021 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.529251e-01 | 0.021 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.532732e-01 | 0.021 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.540050e-01 | 0.020 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.540050e-01 | 0.020 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.551262e-01 | 0.020 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 9.551262e-01 | 0.020 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 9.551262e-01 | 0.020 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 9.557916e-01 | 0.020 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.560752e-01 | 0.020 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 9.565136e-01 | 0.019 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.565136e-01 | 0.019 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.565136e-01 | 0.019 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.569479e-01 | 0.019 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 9.588855e-01 | 0.018 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 9.588855e-01 | 0.018 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.603854e-01 | 0.018 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 9.603854e-01 | 0.018 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 9.611281e-01 | 0.017 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 9.625817e-01 | 0.017 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 9.635640e-01 | 0.016 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 9.635640e-01 | 0.016 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.644463e-01 | 0.016 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 9.652535e-01 | 0.015 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 9.652535e-01 | 0.015 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.665013e-01 | 0.015 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 9.671491e-01 | 0.015 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 9.676449e-01 | 0.014 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.691385e-01 | 0.014 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 9.691385e-01 | 0.014 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.705655e-01 | 0.013 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.706361e-01 | 0.013 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.714699e-01 | 0.013 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 9.719288e-01 | 0.012 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.719288e-01 | 0.012 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 9.722384e-01 | 0.012 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.722384e-01 | 0.012 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.722384e-01 | 0.012 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.741147e-01 | 0.011 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 9.761600e-01 | 0.010 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 9.761600e-01 | 0.010 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.765399e-01 | 0.010 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 9.767974e-01 | 0.010 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 9.774911e-01 | 0.010 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.776277e-01 | 0.010 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.777444e-01 | 0.010 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.778204e-01 | 0.010 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.778805e-01 | 0.010 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.790310e-01 | 0.009 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.801756e-01 | 0.009 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.801756e-01 | 0.009 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.801756e-01 | 0.009 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 9.803637e-01 | 0.009 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.808443e-01 | 0.008 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 9.812578e-01 | 0.008 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 9.812578e-01 | 0.008 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.812578e-01 | 0.008 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 9.812578e-01 | 0.008 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.817437e-01 | 0.008 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.817437e-01 | 0.008 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.818848e-01 | 0.008 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.822810e-01 | 0.008 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.826022e-01 | 0.008 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.842030e-01 | 0.007 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.842273e-01 | 0.007 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.850278e-01 | 0.007 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.850278e-01 | 0.007 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.850278e-01 | 0.007 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.856603e-01 | 0.006 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.858404e-01 | 0.006 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 9.858453e-01 | 0.006 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.858453e-01 | 0.006 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.860970e-01 | 0.006 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.863390e-01 | 0.006 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.873491e-01 | 0.006 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.876040e-01 | 0.005 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.880401e-01 | 0.005 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.880401e-01 | 0.005 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.880401e-01 | 0.005 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.881929e-01 | 0.005 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.886426e-01 | 0.005 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.886700e-01 | 0.005 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 9.886933e-01 | 0.005 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.886933e-01 | 0.005 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.887030e-01 | 0.005 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 9.893109e-01 | 0.005 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.896070e-01 | 0.005 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.902876e-01 | 0.004 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 9.904468e-01 | 0.004 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.904468e-01 | 0.004 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.915889e-01 | 0.004 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 9.923697e-01 | 0.003 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.923697e-01 | 0.003 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.923988e-01 | 0.003 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 9.927867e-01 | 0.003 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.930530e-01 | 0.003 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.931809e-01 | 0.003 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.934457e-01 | 0.003 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.940625e-01 | 0.003 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 9.940625e-01 | 0.003 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.944299e-01 | 0.002 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.950217e-01 | 0.002 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.951331e-01 | 0.002 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.955875e-01 | 0.002 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.961134e-01 | 0.002 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.961134e-01 | 0.002 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.963443e-01 | 0.002 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.963443e-01 | 0.002 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 9.965643e-01 | 0.001 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.967587e-01 | 0.001 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.968701e-01 | 0.001 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.971724e-01 | 0.001 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.971879e-01 | 0.001 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.972266e-01 | 0.001 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.975812e-01 | 0.001 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.976857e-01 | 0.001 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.977855e-01 | 0.001 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.981295e-01 | 0.001 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.981295e-01 | 0.001 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.984070e-01 | 0.001 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.984125e-01 | 0.001 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.985066e-01 | 0.001 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.985398e-01 | 0.001 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.985398e-01 | 0.001 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.985398e-01 | 0.001 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 9.988078e-01 | 0.001 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.988092e-01 | 0.001 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.989348e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.989931e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.990482e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.990837e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.992216e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.992819e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.994879e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.995425e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.995676e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.996175e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.996349e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.996511e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.997397e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.997569e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.997569e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.997756e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.998246e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.998626e-01 | 0.000 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.998887e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999057e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999204e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.999247e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999289e-01 | 0.000 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.999289e-01 | 0.000 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.999415e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999464e-01 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.999509e-01 | 0.000 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.999578e-01 | 0.000 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.999578e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999671e-01 | 0.000 | 1 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999796e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999821e-01 | 0.000 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.999835e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999836e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999846e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999877e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999884e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999920e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999941e-01 | 0.000 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.999963e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999970e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999973e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999990e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999991e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999995e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999997e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999997e-01 | 0.000 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.999999e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999999e-01 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.999999e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 1.000000e+00 | 0.000 | 1 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 1.000000e+00 | 0.000 | 1 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 1.000000e+00 | 0.000 | 1 | 1 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 1.000000e+00 | 0.000 | 1 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 1.000000e+00 | 0.000 | 1 | 1 |
| Diseases of cellular response to stress | R-HSA-9675132 | 1.000000e+00 | 0.000 | 1 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 1.000000e+00 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle, Mitotic | R-HSA-69278 | 1.110223e-16 | 15.955 | 1 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.110223e-16 | 15.955 | 1 | 0 |
| M Phase | R-HSA-68886 | 5.817569e-14 | 13.235 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 9.638068e-12 | 11.016 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.754503e-10 | 9.756 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 5.882272e-10 | 9.230 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.523301e-09 | 8.817 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.112157e-09 | 8.507 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 3.624861e-09 | 8.441 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 4.264633e-09 | 8.370 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 6.072712e-09 | 8.217 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 2.867018e-08 | 7.543 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 3.549503e-08 | 7.450 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 4.291931e-08 | 7.367 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 6.879928e-08 | 7.162 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 8.282131e-08 | 7.082 | 1 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.411034e-07 | 6.850 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.205060e-07 | 6.657 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 3.776637e-07 | 6.423 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 4.437223e-07 | 6.353 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 5.475547e-07 | 6.262 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 6.744696e-07 | 6.171 | 1 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 7.471467e-07 | 6.127 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 9.149396e-07 | 6.039 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.218279e-06 | 5.914 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.068974e-06 | 5.971 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.161044e-06 | 5.935 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.218279e-06 | 5.914 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.216592e-06 | 5.915 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.131088e-06 | 5.947 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.356701e-06 | 5.868 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.411081e-06 | 5.850 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.516212e-06 | 5.819 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.576924e-06 | 5.802 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.665907e-06 | 5.778 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.702694e-06 | 5.769 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.788928e-06 | 5.747 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.943497e-06 | 5.711 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 3.186051e-06 | 5.497 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 3.305071e-06 | 5.481 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 3.483580e-06 | 5.458 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 3.483580e-06 | 5.458 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 4.137715e-06 | 5.383 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 5.032246e-06 | 5.298 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 6.248786e-06 | 5.204 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 6.588673e-06 | 5.181 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 7.698066e-06 | 5.114 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 8.312344e-06 | 5.080 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 9.883431e-06 | 5.005 | 1 | 1 |
| Cell junction organization | R-HSA-446728 | 1.037777e-05 | 4.984 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.119742e-05 | 4.951 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.112087e-05 | 4.954 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.475950e-05 | 4.831 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.498028e-05 | 4.824 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.510247e-05 | 4.821 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.675030e-05 | 4.776 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.638709e-05 | 4.785 | 1 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.823998e-05 | 4.739 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.823998e-05 | 4.739 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.778873e-05 | 4.750 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.825583e-05 | 4.739 | 1 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.928591e-05 | 4.715 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.024896e-05 | 4.694 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 2.138150e-05 | 4.670 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 2.142463e-05 | 4.669 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 2.344301e-05 | 4.630 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.830127e-05 | 4.548 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.830127e-05 | 4.548 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 3.387697e-05 | 4.470 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 3.227640e-05 | 4.491 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.461577e-05 | 4.461 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 3.886357e-05 | 4.410 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 4.081043e-05 | 4.389 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 4.100184e-05 | 4.387 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 4.802673e-05 | 4.319 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 5.194460e-05 | 4.284 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.204053e-05 | 4.284 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 5.654675e-05 | 4.248 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 5.823967e-05 | 4.235 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 6.175618e-05 | 4.209 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 6.254040e-05 | 4.204 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 6.366885e-05 | 4.196 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 7.126080e-05 | 4.147 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 7.368099e-05 | 4.133 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 7.877107e-05 | 4.104 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 8.169287e-05 | 4.088 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 8.174682e-05 | 4.088 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 9.915138e-05 | 4.004 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 9.915138e-05 | 4.004 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 9.915138e-05 | 4.004 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 9.779748e-05 | 4.010 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 9.915138e-05 | 4.004 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 9.674252e-05 | 4.014 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 9.970394e-05 | 4.001 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.014709e-04 | 3.994 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.046726e-04 | 3.980 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.046726e-04 | 3.980 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.124542e-04 | 3.949 | 1 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.252782e-04 | 3.902 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.268450e-04 | 3.897 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.306817e-04 | 3.884 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.463189e-04 | 3.835 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.542631e-04 | 3.812 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.444061e-04 | 3.840 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.552121e-04 | 3.809 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.730417e-04 | 3.762 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 1.786124e-04 | 3.748 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.877159e-04 | 3.726 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.056370e-04 | 3.687 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.020470e-04 | 3.695 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 2.089805e-04 | 3.680 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.161356e-04 | 3.665 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.279217e-04 | 3.642 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.532286e-04 | 3.596 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.722111e-04 | 3.565 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.722111e-04 | 3.565 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.790029e-04 | 3.554 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 2.941579e-04 | 3.531 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 2.920849e-04 | 3.534 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.911629e-04 | 3.536 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.941579e-04 | 3.531 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.106526e-04 | 3.508 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 3.300804e-04 | 3.481 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 3.309378e-04 | 3.480 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 3.380900e-04 | 3.471 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 3.554560e-04 | 3.449 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.572159e-04 | 3.447 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 3.704117e-04 | 3.431 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 3.460124e-04 | 3.461 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 3.721755e-04 | 3.429 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 3.679255e-04 | 3.434 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 3.607049e-04 | 3.443 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 3.554560e-04 | 3.449 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.787311e-04 | 3.422 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.787311e-04 | 3.422 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 4.192529e-04 | 3.378 | 1 | 1 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 4.301620e-04 | 3.366 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 4.301620e-04 | 3.366 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 4.700096e-04 | 3.328 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 4.900565e-04 | 3.310 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 4.947199e-04 | 3.306 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 4.993494e-04 | 3.302 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 5.045080e-04 | 3.297 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 5.551004e-04 | 3.256 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 5.752057e-04 | 3.240 | 1 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 6.171417e-04 | 3.210 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 6.457353e-04 | 3.190 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 5.840350e-04 | 3.234 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 6.468789e-04 | 3.189 | 1 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 7.092189e-04 | 3.149 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 7.092189e-04 | 3.149 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 7.148994e-04 | 3.146 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 7.217409e-04 | 3.142 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 7.604213e-04 | 3.119 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 7.687939e-04 | 3.114 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 7.836454e-04 | 3.106 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 7.889610e-04 | 3.103 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 8.305398e-04 | 3.081 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 8.347880e-04 | 3.078 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 8.762165e-04 | 3.057 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 8.762165e-04 | 3.057 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 8.762165e-04 | 3.057 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 9.084175e-04 | 3.042 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 9.731020e-04 | 3.012 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 9.458716e-04 | 3.024 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.007583e-03 | 2.997 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.034387e-03 | 2.985 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.040155e-03 | 2.983 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.055610e-03 | 2.976 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.089537e-03 | 2.963 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.185866e-03 | 2.926 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.217348e-03 | 2.915 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.357848e-03 | 2.867 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.360270e-03 | 2.866 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.376640e-03 | 2.861 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.476004e-03 | 2.831 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.484913e-03 | 2.828 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.510255e-03 | 2.821 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.525266e-03 | 2.817 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.600141e-03 | 2.796 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.600141e-03 | 2.796 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.625122e-03 | 2.789 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.788477e-03 | 2.748 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.737600e-03 | 2.760 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.658390e-03 | 2.780 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 1.827181e-03 | 2.738 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.658988e-03 | 2.780 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.729057e-03 | 2.762 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 2.120984e-03 | 2.673 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 2.226736e-03 | 2.652 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 2.233151e-03 | 2.651 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.353217e-03 | 2.628 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 2.359434e-03 | 2.627 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 2.389358e-03 | 2.622 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.479555e-03 | 2.606 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.479555e-03 | 2.606 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.586216e-03 | 2.587 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 2.614212e-03 | 2.583 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.837649e-03 | 2.547 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.876080e-03 | 2.541 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.876080e-03 | 2.541 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.885981e-03 | 2.540 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.915190e-03 | 2.535 | 1 | 0 |
| Attenuation phase | R-HSA-3371568 | 3.006434e-03 | 2.522 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 3.145340e-03 | 2.502 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 3.208519e-03 | 2.494 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 3.223460e-03 | 2.492 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 4.144979e-03 | 2.382 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 4.144979e-03 | 2.382 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 3.907101e-03 | 2.408 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 3.683542e-03 | 2.434 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 4.227899e-03 | 2.374 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 4.013096e-03 | 2.397 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 4.144979e-03 | 2.382 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 4.227899e-03 | 2.374 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 3.924779e-03 | 2.406 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 3.633859e-03 | 2.440 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 4.370591e-03 | 2.359 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 4.434531e-03 | 2.353 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 4.575442e-03 | 2.340 | 1 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 4.732382e-03 | 2.325 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 4.732382e-03 | 2.325 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 4.856008e-03 | 2.314 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 4.869245e-03 | 2.313 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 4.952998e-03 | 2.305 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 5.035840e-03 | 2.298 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 5.127129e-03 | 2.290 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 5.140076e-03 | 2.289 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 5.236060e-03 | 2.281 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 5.330257e-03 | 2.273 | 0 | 0 |
| S Phase | R-HSA-69242 | 6.027754e-03 | 2.220 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 6.082963e-03 | 2.216 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 6.115826e-03 | 2.214 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 6.115826e-03 | 2.214 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 6.227780e-03 | 2.206 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 6.390977e-03 | 2.194 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 6.416262e-03 | 2.193 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 6.509202e-03 | 2.186 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 6.557097e-03 | 2.183 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 6.587608e-03 | 2.181 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 6.765017e-03 | 2.170 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 7.105901e-03 | 2.148 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 7.347340e-03 | 2.134 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 7.445504e-03 | 2.128 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 7.527121e-03 | 2.123 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 7.593491e-03 | 2.120 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 7.886078e-03 | 2.103 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 8.027368e-03 | 2.095 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 9.601767e-03 | 2.018 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 8.370629e-03 | 2.077 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 9.727176e-03 | 2.012 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 9.699197e-03 | 2.013 | 1 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 9.814706e-03 | 2.008 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 8.530375e-03 | 2.069 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 9.727176e-03 | 2.012 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 9.908341e-03 | 2.004 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.015838e-02 | 1.993 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.022540e-02 | 1.990 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.027668e-02 | 1.988 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.027668e-02 | 1.988 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.040174e-02 | 1.983 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.053299e-02 | 1.977 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.151089e-02 | 1.939 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 1.152040e-02 | 1.939 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.152040e-02 | 1.939 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.152040e-02 | 1.939 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.157501e-02 | 1.936 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.157501e-02 | 1.936 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.157501e-02 | 1.936 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.168976e-02 | 1.932 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.206861e-02 | 1.918 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.317754e-02 | 1.880 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.317754e-02 | 1.880 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.317754e-02 | 1.880 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.317754e-02 | 1.880 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.317754e-02 | 1.880 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 1.317754e-02 | 1.880 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.317754e-02 | 1.880 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.324570e-02 | 1.878 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.324570e-02 | 1.878 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.324570e-02 | 1.878 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.348757e-02 | 1.870 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.368003e-02 | 1.864 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.424265e-02 | 1.846 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 1.497784e-02 | 1.825 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.541032e-02 | 1.812 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.566473e-02 | 1.805 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.582533e-02 | 1.801 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.597469e-02 | 1.797 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.616238e-02 | 1.791 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.616238e-02 | 1.791 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.636846e-02 | 1.786 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.639280e-02 | 1.785 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.639280e-02 | 1.785 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.639280e-02 | 1.785 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 1.639280e-02 | 1.785 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.657814e-02 | 1.780 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.674464e-02 | 1.776 | 1 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.674464e-02 | 1.776 | 1 | 1 |
| Frs2-mediated activation | R-HSA-170968 | 1.674464e-02 | 1.776 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.092376e-02 | 1.679 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 2.092376e-02 | 1.679 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 2.092376e-02 | 1.679 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 2.129815e-02 | 1.672 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.860385e-02 | 1.730 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.129815e-02 | 1.672 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 2.092376e-02 | 1.679 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.091486e-02 | 1.680 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.108130e-02 | 1.676 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 2.047706e-02 | 1.689 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.752718e-02 | 1.756 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 2.132323e-02 | 1.671 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 2.232060e-02 | 1.651 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.232060e-02 | 1.651 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.244765e-02 | 1.649 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 2.324617e-02 | 1.634 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.324617e-02 | 1.634 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.324617e-02 | 1.634 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.356234e-02 | 1.628 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 2.356234e-02 | 1.628 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 2.431705e-02 | 1.614 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.501294e-02 | 1.602 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 2.501294e-02 | 1.602 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.514279e-02 | 1.600 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 2.531686e-02 | 1.597 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.531686e-02 | 1.597 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.577890e-02 | 1.589 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 2.593007e-02 | 1.586 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 2.593007e-02 | 1.586 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 2.698114e-02 | 1.569 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.749325e-02 | 1.561 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 2.749325e-02 | 1.561 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 2.802957e-02 | 1.552 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.802957e-02 | 1.552 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 2.942047e-02 | 1.531 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 2.958608e-02 | 1.529 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 3.032735e-02 | 1.518 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 3.074160e-02 | 1.512 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 3.074160e-02 | 1.512 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 3.110211e-02 | 1.507 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 3.260847e-02 | 1.487 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.260847e-02 | 1.487 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 3.353241e-02 | 1.475 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.395773e-02 | 1.469 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 3.483652e-02 | 1.458 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 3.665647e-02 | 1.436 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.896294e-02 | 1.409 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 4.006249e-02 | 1.397 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 4.099578e-02 | 1.387 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 4.119896e-02 | 1.385 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 4.136913e-02 | 1.383 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 4.136913e-02 | 1.383 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 4.171990e-02 | 1.380 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 4.194696e-02 | 1.377 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.194696e-02 | 1.377 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 4.248724e-02 | 1.372 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.259448e-02 | 1.371 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 4.422618e-02 | 1.354 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 4.548590e-02 | 1.342 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 4.712768e-02 | 1.327 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.712768e-02 | 1.327 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 4.760003e-02 | 1.322 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 4.853827e-02 | 1.314 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 4.912546e-02 | 1.309 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 5.045444e-02 | 1.297 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 5.045444e-02 | 1.297 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 5.087383e-02 | 1.294 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 5.087383e-02 | 1.294 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 5.260908e-02 | 1.279 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 5.373482e-02 | 1.270 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 5.393261e-02 | 1.268 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 5.425241e-02 | 1.266 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 6.967272e-02 | 1.157 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 5.629443e-02 | 1.250 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 5.629443e-02 | 1.250 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 5.629443e-02 | 1.250 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 7.047722e-02 | 1.152 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 7.047722e-02 | 1.152 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 7.047722e-02 | 1.152 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 7.047722e-02 | 1.152 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 6.811698e-02 | 1.167 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 6.036936e-02 | 1.219 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.867644e-02 | 1.232 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 6.691262e-02 | 1.174 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 6.189204e-02 | 1.208 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 5.835083e-02 | 1.234 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 5.801225e-02 | 1.236 | 0 | 0 |
| Protein folding | R-HSA-391251 | 6.208935e-02 | 1.207 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 6.577169e-02 | 1.182 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 5.912982e-02 | 1.228 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 6.720857e-02 | 1.173 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 5.745516e-02 | 1.241 | 0 | 0 |
| Kinesins | R-HSA-983189 | 7.320384e-02 | 1.135 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 6.150268e-02 | 1.211 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 7.382294e-02 | 1.132 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 7.444150e-02 | 1.128 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 7.963883e-02 | 1.099 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 8.116091e-02 | 1.091 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 8.235933e-02 | 1.084 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 8.235933e-02 | 1.084 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 8.235933e-02 | 1.084 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 8.331094e-02 | 1.079 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 8.331094e-02 | 1.079 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 8.331094e-02 | 1.079 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 8.331094e-02 | 1.079 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 8.331094e-02 | 1.079 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 8.374241e-02 | 1.077 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.376343e-02 | 1.077 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 8.452062e-02 | 1.073 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 8.562963e-02 | 1.067 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 8.600534e-02 | 1.065 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 8.600534e-02 | 1.065 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 8.600534e-02 | 1.065 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 8.600534e-02 | 1.065 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 8.600534e-02 | 1.065 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 8.609088e-02 | 1.065 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 8.609088e-02 | 1.065 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 8.769946e-02 | 1.057 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 8.941267e-02 | 1.049 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 9.347045e-02 | 1.029 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 9.347045e-02 | 1.029 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 9.496821e-02 | 1.022 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 9.496821e-02 | 1.022 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 9.496821e-02 | 1.022 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 9.496821e-02 | 1.022 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 9.496821e-02 | 1.022 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 9.496821e-02 | 1.022 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 9.592137e-02 | 1.018 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 9.608284e-02 | 1.017 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 9.651182e-02 | 1.015 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 9.651182e-02 | 1.015 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 9.812656e-02 | 1.008 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 9.831179e-02 | 1.007 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 9.831179e-02 | 1.007 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.021166e-01 | 0.991 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.029763e-01 | 0.987 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 1.030209e-01 | 0.987 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.030209e-01 | 0.987 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.030209e-01 | 0.987 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.030209e-01 | 0.987 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.030209e-01 | 0.987 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.060997e-01 | 0.974 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.072176e-01 | 0.970 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 1.076354e-01 | 0.968 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.078711e-01 | 0.967 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 1.093682e-01 | 0.961 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.093682e-01 | 0.961 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.093682e-01 | 0.961 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.093682e-01 | 0.961 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.118374e-01 | 0.951 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.224089e-01 | 0.912 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 1.224089e-01 | 0.912 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.224089e-01 | 0.912 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 1.224089e-01 | 0.912 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 1.224089e-01 | 0.912 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 1.224089e-01 | 0.912 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 1.224089e-01 | 0.912 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.232048e-01 | 0.909 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 1.236047e-01 | 0.908 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.316442e-01 | 0.881 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 1.316442e-01 | 0.881 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.335279e-01 | 0.874 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.379143e-01 | 0.860 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.385796e-01 | 0.858 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.387981e-01 | 0.858 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.397016e-01 | 0.855 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 1.403320e-01 | 0.853 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.403320e-01 | 0.853 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 1.403320e-01 | 0.853 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.579401e-01 | 0.802 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.579401e-01 | 0.802 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.514704e-01 | 0.820 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 1.514704e-01 | 0.820 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 1.514704e-01 | 0.820 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 1.817000e-01 | 0.741 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 1.817000e-01 | 0.741 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 2.127087e-01 | 0.672 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 2.127087e-01 | 0.672 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.604545e-01 | 0.795 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.604545e-01 | 0.795 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.604545e-01 | 0.795 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.444769e-01 | 0.840 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 1.444769e-01 | 0.840 | 1 | 1 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.873731e-01 | 0.727 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 2.047295e-01 | 0.689 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 2.119395e-01 | 0.674 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.449911e-01 | 0.839 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 1.705224e-01 | 0.768 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.647132e-01 | 0.783 | 1 | 1 |
| G1 Phase | R-HSA-69236 | 1.647132e-01 | 0.783 | 1 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.604545e-01 | 0.795 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 2.127087e-01 | 0.672 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 2.127087e-01 | 0.672 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 1.813817e-01 | 0.741 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.566127e-01 | 0.805 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 2.074210e-01 | 0.683 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.435775e-01 | 0.843 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 1.942950e-01 | 0.712 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 1.828477e-01 | 0.738 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.859236e-01 | 0.731 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.919427e-01 | 0.717 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.813817e-01 | 0.741 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.848879e-01 | 0.733 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.651240e-01 | 0.782 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 1.817000e-01 | 0.741 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.579401e-01 | 0.802 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.604545e-01 | 0.795 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.029861e-01 | 0.693 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.539770e-01 | 0.813 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.539980e-01 | 0.812 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.086500e-01 | 0.681 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 1.817000e-01 | 0.741 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 1.859236e-01 | 0.731 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.630470e-01 | 0.788 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.002553e-01 | 0.698 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 2.029861e-01 | 0.693 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.514962e-01 | 0.820 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 1.738539e-01 | 0.760 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 2.044780e-01 | 0.689 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.556216e-01 | 0.808 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.713010e-01 | 0.766 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.108214e-01 | 0.676 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.156724e-01 | 0.666 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.158321e-01 | 0.666 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 2.208508e-01 | 0.656 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 2.208508e-01 | 0.656 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.225303e-01 | 0.653 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 2.225303e-01 | 0.653 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 2.229171e-01 | 0.652 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 2.231436e-01 | 0.651 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.232692e-01 | 0.651 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.246061e-01 | 0.649 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 2.251440e-01 | 0.648 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 2.251440e-01 | 0.648 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.251440e-01 | 0.648 | 0 | 0 |
| Abasic sugar-phosphate removal via the single-nucleotide replacement pathway | R-HSA-73930 | 2.272998e-01 | 0.643 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 2.272998e-01 | 0.643 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 2.272998e-01 | 0.643 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 2.272998e-01 | 0.643 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 2.272998e-01 | 0.643 | 0 | 0 |
| Inhibition of membrane repair | R-HSA-9635644 | 2.272998e-01 | 0.643 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 2.272998e-01 | 0.643 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 2.909502e-01 | 0.536 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 2.909502e-01 | 0.536 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 2.909502e-01 | 0.536 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 2.909502e-01 | 0.536 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 2.909502e-01 | 0.536 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 2.909502e-01 | 0.536 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 2.909502e-01 | 0.536 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 2.909502e-01 | 0.536 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 2.909502e-01 | 0.536 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 2.909502e-01 | 0.536 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 2.909502e-01 | 0.536 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 2.909502e-01 | 0.536 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 2.909502e-01 | 0.536 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 2.909502e-01 | 0.536 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 2.909502e-01 | 0.536 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 2.909502e-01 | 0.536 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 2.909502e-01 | 0.536 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 2.909502e-01 | 0.536 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 3.493610e-01 | 0.457 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 3.493610e-01 | 0.457 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 3.493610e-01 | 0.457 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 3.493610e-01 | 0.457 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 3.493610e-01 | 0.457 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 3.493610e-01 | 0.457 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 2.441634e-01 | 0.612 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 2.757805e-01 | 0.559 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 2.757805e-01 | 0.559 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 4.029631e-01 | 0.395 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.029631e-01 | 0.395 | 1 | 1 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 4.029631e-01 | 0.395 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.029631e-01 | 0.395 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 4.029631e-01 | 0.395 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 4.029631e-01 | 0.395 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.029631e-01 | 0.395 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 4.029631e-01 | 0.395 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 4.029631e-01 | 0.395 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 3.073200e-01 | 0.512 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 3.073200e-01 | 0.512 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.477369e-01 | 0.606 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.477369e-01 | 0.606 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.706522e-01 | 0.568 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 3.385805e-01 | 0.470 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 3.385805e-01 | 0.470 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 3.385805e-01 | 0.470 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 3.385805e-01 | 0.470 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 3.385805e-01 | 0.470 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 4.521522e-01 | 0.345 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 4.521522e-01 | 0.345 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 4.521522e-01 | 0.345 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 4.521522e-01 | 0.345 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 4.521522e-01 | 0.345 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 4.521522e-01 | 0.345 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 3.693939e-01 | 0.433 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 3.170329e-01 | 0.499 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 3.170329e-01 | 0.499 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 3.403075e-01 | 0.468 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 3.403075e-01 | 0.468 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 3.996220e-01 | 0.398 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 3.996220e-01 | 0.398 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 3.996220e-01 | 0.398 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 3.996220e-01 | 0.398 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 3.996220e-01 | 0.398 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 3.996220e-01 | 0.398 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 3.996220e-01 | 0.398 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 3.996220e-01 | 0.398 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 3.996220e-01 | 0.398 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 2.789440e-01 | 0.554 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 4.291522e-01 | 0.367 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.291522e-01 | 0.367 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 4.291522e-01 | 0.367 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 3.866032e-01 | 0.413 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 3.866032e-01 | 0.413 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.545926e-01 | 0.450 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.545926e-01 | 0.450 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 3.545926e-01 | 0.450 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 2.870839e-01 | 0.542 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.738597e-01 | 0.427 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 4.578944e-01 | 0.339 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 4.578944e-01 | 0.339 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 2.342725e-01 | 0.630 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 3.788899e-01 | 0.421 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 3.444192e-01 | 0.463 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 4.543640e-01 | 0.343 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 4.543640e-01 | 0.343 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 4.124492e-01 | 0.385 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 4.124492e-01 | 0.385 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 4.124492e-01 | 0.385 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 3.390919e-01 | 0.470 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.115821e-01 | 0.386 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 4.291362e-01 | 0.367 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.266327e-01 | 0.370 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.266327e-01 | 0.370 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 4.457251e-01 | 0.351 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 3.797491e-01 | 0.421 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 3.797491e-01 | 0.421 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 2.789440e-01 | 0.554 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 2.342725e-01 | 0.630 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.738597e-01 | 0.427 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 2.969702e-01 | 0.527 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 3.361894e-01 | 0.473 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.662654e-01 | 0.575 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 4.023822e-01 | 0.395 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 3.403075e-01 | 0.468 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 3.635233e-01 | 0.439 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.916759e-01 | 0.535 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 4.500212e-01 | 0.347 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.706522e-01 | 0.568 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 2.467784e-01 | 0.608 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 4.311973e-01 | 0.365 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 3.170329e-01 | 0.499 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 2.757805e-01 | 0.559 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.073200e-01 | 0.512 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 2.298456e-01 | 0.639 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 2.441634e-01 | 0.612 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 3.403075e-01 | 0.468 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 3.996220e-01 | 0.398 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 3.996220e-01 | 0.398 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 3.191744e-01 | 0.496 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.425745e-01 | 0.615 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 3.686645e-01 | 0.433 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 3.403075e-01 | 0.468 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.266327e-01 | 0.370 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.768198e-01 | 0.558 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 4.122037e-01 | 0.385 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 2.608481e-01 | 0.584 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 3.385805e-01 | 0.470 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 4.521522e-01 | 0.345 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 4.521522e-01 | 0.345 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 2.384247e-01 | 0.623 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 4.481001e-01 | 0.349 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 3.571452e-01 | 0.447 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 3.170329e-01 | 0.499 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 3.929245e-01 | 0.406 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 3.827311e-01 | 0.417 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 3.686645e-01 | 0.433 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 3.686645e-01 | 0.433 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 3.686645e-01 | 0.433 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 3.686645e-01 | 0.433 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 4.457251e-01 | 0.351 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.969702e-01 | 0.527 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.960414e-01 | 0.529 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 4.029631e-01 | 0.395 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 2.937838e-01 | 0.532 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 3.452799e-01 | 0.462 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 4.578944e-01 | 0.339 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 2.467784e-01 | 0.608 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 2.874906e-01 | 0.541 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 3.162587e-01 | 0.500 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 2.953316e-01 | 0.530 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 3.418832e-01 | 0.466 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 2.757805e-01 | 0.559 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 3.996220e-01 | 0.398 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 2.909502e-01 | 0.536 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 2.441634e-01 | 0.612 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 2.757805e-01 | 0.559 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 4.029631e-01 | 0.395 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 4.029631e-01 | 0.395 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.073200e-01 | 0.512 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 2.477369e-01 | 0.606 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 2.477369e-01 | 0.606 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 3.385805e-01 | 0.470 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 4.521522e-01 | 0.345 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 3.693939e-01 | 0.433 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 2.627473e-01 | 0.580 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 3.930777e-01 | 0.406 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 3.512115e-01 | 0.454 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 4.115821e-01 | 0.386 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.474253e-01 | 0.607 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 2.953316e-01 | 0.530 | 1 | 1 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 4.094774e-01 | 0.388 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 2.328020e-01 | 0.633 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 3.396134e-01 | 0.469 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.592218e-01 | 0.586 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.821508e-01 | 0.550 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 4.457251e-01 | 0.351 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.636180e-01 | 0.579 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 3.073200e-01 | 0.512 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 3.738597e-01 | 0.427 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 4.578944e-01 | 0.339 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 3.635233e-01 | 0.439 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 3.930777e-01 | 0.406 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 4.543640e-01 | 0.343 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.304261e-01 | 0.637 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 2.441634e-01 | 0.612 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 2.757805e-01 | 0.559 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 4.029631e-01 | 0.395 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 4.521522e-01 | 0.345 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.749923e-01 | 0.561 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 4.101469e-01 | 0.387 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 4.101469e-01 | 0.387 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 2.779929e-01 | 0.556 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 3.824828e-01 | 0.417 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 3.788899e-01 | 0.421 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 4.124492e-01 | 0.385 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 3.644183e-01 | 0.438 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 2.757805e-01 | 0.559 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.029631e-01 | 0.395 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 2.467784e-01 | 0.608 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 4.320830e-01 | 0.364 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 3.686645e-01 | 0.433 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 4.311973e-01 | 0.365 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 3.403075e-01 | 0.468 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 3.930777e-01 | 0.406 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.345596e-01 | 0.630 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 4.355047e-01 | 0.361 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 3.635233e-01 | 0.439 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 3.866032e-01 | 0.413 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 3.139001e-01 | 0.503 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 3.512115e-01 | 0.454 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 3.385805e-01 | 0.470 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 2.467784e-01 | 0.608 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 4.311973e-01 | 0.365 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.301446e-01 | 0.638 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 3.109948e-01 | 0.507 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 4.521522e-01 | 0.345 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.627129e-01 | 0.581 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.477369e-01 | 0.606 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.345596e-01 | 0.630 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 4.320830e-01 | 0.364 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 2.916759e-01 | 0.535 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 2.937838e-01 | 0.532 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 4.291522e-01 | 0.367 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 4.578944e-01 | 0.339 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 3.487585e-01 | 0.457 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 3.073200e-01 | 0.512 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 4.291522e-01 | 0.367 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 4.457251e-01 | 0.351 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 3.385805e-01 | 0.470 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 4.521522e-01 | 0.345 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 3.631696e-01 | 0.440 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 3.996220e-01 | 0.398 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 4.578944e-01 | 0.339 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 4.500212e-01 | 0.347 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.073200e-01 | 0.512 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 3.645584e-01 | 0.438 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 3.545926e-01 | 0.450 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.738597e-01 | 0.427 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 4.686411e-01 | 0.329 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 4.686411e-01 | 0.329 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.713532e-01 | 0.327 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.713532e-01 | 0.327 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 4.713532e-01 | 0.327 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.762709e-01 | 0.322 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 4.762709e-01 | 0.322 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 4.762709e-01 | 0.322 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 4.785087e-01 | 0.320 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 4.857780e-01 | 0.314 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 4.857780e-01 | 0.314 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 4.857780e-01 | 0.314 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 4.857780e-01 | 0.314 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 4.857780e-01 | 0.314 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 4.857780e-01 | 0.314 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 4.857780e-01 | 0.314 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 4.870252e-01 | 0.312 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 4.946574e-01 | 0.306 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.946574e-01 | 0.306 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 4.972914e-01 | 0.303 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 4.972914e-01 | 0.303 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 4.972914e-01 | 0.303 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 4.972914e-01 | 0.303 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 4.972914e-01 | 0.303 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 4.972914e-01 | 0.303 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 4.972914e-01 | 0.303 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 4.972914e-01 | 0.303 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 4.972914e-01 | 0.303 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 4.972914e-01 | 0.303 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 4.972914e-01 | 0.303 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 4.972914e-01 | 0.303 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 4.972914e-01 | 0.303 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 4.972914e-01 | 0.303 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 4.972914e-01 | 0.303 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 4.972914e-01 | 0.303 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 4.973676e-01 | 0.303 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 5.006234e-01 | 0.300 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 5.018761e-01 | 0.299 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 5.051450e-01 | 0.297 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 5.051450e-01 | 0.297 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 5.051450e-01 | 0.297 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 5.051450e-01 | 0.297 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 5.051450e-01 | 0.297 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 5.051450e-01 | 0.297 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 5.055614e-01 | 0.296 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.127494e-01 | 0.290 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.127494e-01 | 0.290 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 5.127494e-01 | 0.290 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 5.127494e-01 | 0.290 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 5.127494e-01 | 0.290 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 5.187950e-01 | 0.285 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 5.187950e-01 | 0.285 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 5.187950e-01 | 0.285 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.188189e-01 | 0.285 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.188189e-01 | 0.285 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 5.229745e-01 | 0.282 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 5.229745e-01 | 0.282 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 5.249806e-01 | 0.280 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 5.387138e-01 | 0.269 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 5.387138e-01 | 0.269 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.387138e-01 | 0.269 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.387138e-01 | 0.269 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 5.387138e-01 | 0.269 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 5.387138e-01 | 0.269 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 5.387138e-01 | 0.269 | 0 | 0 |
| Hydrolysis of LPE | R-HSA-1483152 | 5.387138e-01 | 0.269 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 5.387138e-01 | 0.269 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 5.387138e-01 | 0.269 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 5.387288e-01 | 0.269 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 5.387698e-01 | 0.269 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 5.387698e-01 | 0.269 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 5.387698e-01 | 0.269 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.387698e-01 | 0.269 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 5.387698e-01 | 0.269 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 5.393427e-01 | 0.268 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 5.393427e-01 | 0.268 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 5.393427e-01 | 0.268 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 5.446119e-01 | 0.264 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 5.572849e-01 | 0.254 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 5.572849e-01 | 0.254 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.572849e-01 | 0.254 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 5.576722e-01 | 0.254 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 5.577575e-01 | 0.254 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 5.593768e-01 | 0.252 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 5.593768e-01 | 0.252 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 5.593768e-01 | 0.252 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 5.593768e-01 | 0.252 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 5.593768e-01 | 0.252 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 5.638126e-01 | 0.249 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 5.638126e-01 | 0.249 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 5.638126e-01 | 0.249 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 5.638126e-01 | 0.249 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 5.638126e-01 | 0.249 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 5.638126e-01 | 0.249 | 0 | 0 |
| Immune System | R-HSA-168256 | 5.688606e-01 | 0.245 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 5.702863e-01 | 0.244 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 5.704283e-01 | 0.244 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 5.745016e-01 | 0.241 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 5.767254e-01 | 0.239 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 5.767254e-01 | 0.239 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 5.767254e-01 | 0.239 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 5.767254e-01 | 0.239 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 5.767254e-01 | 0.239 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 5.767254e-01 | 0.239 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 5.767254e-01 | 0.239 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 5.767254e-01 | 0.239 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 5.767254e-01 | 0.239 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 5.767254e-01 | 0.239 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 5.767254e-01 | 0.239 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 5.767254e-01 | 0.239 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 5.767254e-01 | 0.239 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 5.767254e-01 | 0.239 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 5.767254e-01 | 0.239 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 5.767254e-01 | 0.239 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 5.767254e-01 | 0.239 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 5.767254e-01 | 0.239 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 5.767254e-01 | 0.239 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 5.767254e-01 | 0.239 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 5.767254e-01 | 0.239 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 5.788751e-01 | 0.237 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 5.788751e-01 | 0.237 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 5.788751e-01 | 0.237 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 5.869428e-01 | 0.231 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 5.869428e-01 | 0.231 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 5.878623e-01 | 0.231 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 5.878623e-01 | 0.231 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 5.878623e-01 | 0.231 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 5.878623e-01 | 0.231 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 5.878623e-01 | 0.231 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 5.878623e-01 | 0.231 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 5.878623e-01 | 0.231 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 5.878623e-01 | 0.231 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 5.909629e-01 | 0.228 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 5.935257e-01 | 0.227 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 5.978200e-01 | 0.223 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 5.978200e-01 | 0.223 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 6.014135e-01 | 0.221 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 6.109126e-01 | 0.214 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.109126e-01 | 0.214 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.109126e-01 | 0.214 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 6.116068e-01 | 0.214 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 6.116068e-01 | 0.214 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 6.116068e-01 | 0.214 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 6.116068e-01 | 0.214 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 6.116068e-01 | 0.214 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.116068e-01 | 0.214 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 6.116068e-01 | 0.214 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 6.116068e-01 | 0.214 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 6.116068e-01 | 0.214 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 6.116068e-01 | 0.214 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.116068e-01 | 0.214 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 6.116068e-01 | 0.214 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 6.155922e-01 | 0.211 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 6.161980e-01 | 0.210 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 6.223323e-01 | 0.206 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 6.277427e-01 | 0.202 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 6.294701e-01 | 0.201 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 6.310243e-01 | 0.200 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 6.329648e-01 | 0.199 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 6.329648e-01 | 0.199 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 6.329648e-01 | 0.199 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 6.329648e-01 | 0.199 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 6.329648e-01 | 0.199 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 6.329648e-01 | 0.199 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 6.329648e-01 | 0.199 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 6.339990e-01 | 0.198 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 6.361098e-01 | 0.196 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 6.361098e-01 | 0.196 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 6.430395e-01 | 0.192 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 6.430395e-01 | 0.192 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 6.430395e-01 | 0.192 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 6.436155e-01 | 0.191 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 6.436155e-01 | 0.191 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 6.436155e-01 | 0.191 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 6.436155e-01 | 0.191 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 6.436155e-01 | 0.191 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 6.436155e-01 | 0.191 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.436155e-01 | 0.191 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 6.436155e-01 | 0.191 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 6.436155e-01 | 0.191 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 6.436155e-01 | 0.191 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 6.436155e-01 | 0.191 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 6.436155e-01 | 0.191 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 6.436155e-01 | 0.191 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 6.512167e-01 | 0.186 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 6.512167e-01 | 0.186 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 6.512167e-01 | 0.186 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 6.540269e-01 | 0.184 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 6.540269e-01 | 0.184 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 6.540269e-01 | 0.184 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 6.540269e-01 | 0.184 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 6.540269e-01 | 0.184 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 6.540269e-01 | 0.184 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 6.540269e-01 | 0.184 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 6.540269e-01 | 0.184 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 6.604551e-01 | 0.180 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 6.604551e-01 | 0.180 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 6.673520e-01 | 0.176 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 6.673520e-01 | 0.176 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 6.678475e-01 | 0.175 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 6.684321e-01 | 0.175 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 6.729881e-01 | 0.172 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 6.729881e-01 | 0.172 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 6.729881e-01 | 0.172 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 6.729881e-01 | 0.172 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 6.729881e-01 | 0.172 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 6.729881e-01 | 0.172 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 6.729881e-01 | 0.172 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 6.729881e-01 | 0.172 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 6.729881e-01 | 0.172 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 6.729881e-01 | 0.172 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 6.729881e-01 | 0.172 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 6.729881e-01 | 0.172 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 6.729881e-01 | 0.172 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 6.729881e-01 | 0.172 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 6.729881e-01 | 0.172 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 6.729881e-01 | 0.172 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 6.729881e-01 | 0.172 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 6.741122e-01 | 0.171 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 6.741122e-01 | 0.171 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 6.741122e-01 | 0.171 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 6.742593e-01 | 0.171 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 6.748203e-01 | 0.171 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 6.797251e-01 | 0.168 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 6.813946e-01 | 0.167 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 6.838908e-01 | 0.165 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 6.838908e-01 | 0.165 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 6.838908e-01 | 0.165 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 6.896639e-01 | 0.161 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 6.896639e-01 | 0.161 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 6.931102e-01 | 0.159 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 6.932387e-01 | 0.159 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 6.932387e-01 | 0.159 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 6.932387e-01 | 0.159 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 6.932387e-01 | 0.159 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 6.932387e-01 | 0.159 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 6.932387e-01 | 0.159 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 6.932387e-01 | 0.159 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 6.932387e-01 | 0.159 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 6.950163e-01 | 0.158 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 6.955875e-01 | 0.158 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 6.967052e-01 | 0.157 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.969067e-01 | 0.157 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 6.993484e-01 | 0.155 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 6.999414e-01 | 0.155 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 6.999414e-01 | 0.155 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 6.999414e-01 | 0.155 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 6.999414e-01 | 0.155 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 6.999414e-01 | 0.155 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 6.999414e-01 | 0.155 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 6.999414e-01 | 0.155 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 6.999414e-01 | 0.155 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 6.999414e-01 | 0.155 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 6.999414e-01 | 0.155 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 6.999414e-01 | 0.155 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 7.001478e-01 | 0.155 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 7.040798e-01 | 0.152 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 7.053752e-01 | 0.152 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 7.053752e-01 | 0.152 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.053752e-01 | 0.152 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 7.114279e-01 | 0.148 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 7.114279e-01 | 0.148 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 7.114279e-01 | 0.148 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 7.114279e-01 | 0.148 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 7.142244e-01 | 0.146 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 7.142244e-01 | 0.146 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 7.142244e-01 | 0.146 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 7.167025e-01 | 0.145 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 7.177001e-01 | 0.144 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 7.182929e-01 | 0.144 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 7.182929e-01 | 0.144 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 7.182929e-01 | 0.144 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 7.200785e-01 | 0.143 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 7.200785e-01 | 0.143 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 7.209954e-01 | 0.142 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 7.246587e-01 | 0.140 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 7.246746e-01 | 0.140 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 7.246746e-01 | 0.140 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 7.246746e-01 | 0.140 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 7.246746e-01 | 0.140 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 7.246746e-01 | 0.140 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 7.246746e-01 | 0.140 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 7.246746e-01 | 0.140 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 7.246746e-01 | 0.140 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 7.246746e-01 | 0.140 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 7.246746e-01 | 0.140 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 7.246746e-01 | 0.140 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 7.285246e-01 | 0.138 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 7.287044e-01 | 0.137 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 7.287044e-01 | 0.137 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 7.289930e-01 | 0.137 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.304333e-01 | 0.136 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.304333e-01 | 0.136 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 7.363739e-01 | 0.133 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 7.373055e-01 | 0.132 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 7.441354e-01 | 0.128 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 7.450950e-01 | 0.128 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.450950e-01 | 0.128 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 7.450950e-01 | 0.128 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 7.453501e-01 | 0.128 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 7.459969e-01 | 0.127 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 7.471977e-01 | 0.127 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 7.473705e-01 | 0.126 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 7.473705e-01 | 0.126 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 7.473705e-01 | 0.126 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 7.473705e-01 | 0.126 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 7.473705e-01 | 0.126 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 7.473705e-01 | 0.126 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 7.473705e-01 | 0.126 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 7.473705e-01 | 0.126 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 7.473705e-01 | 0.126 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 7.510348e-01 | 0.124 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 7.546092e-01 | 0.122 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 7.554300e-01 | 0.122 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 7.554300e-01 | 0.122 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 7.554300e-01 | 0.122 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 7.554300e-01 | 0.122 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 7.568178e-01 | 0.121 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 7.568178e-01 | 0.121 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 7.568288e-01 | 0.121 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 7.606283e-01 | 0.119 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 7.606283e-01 | 0.119 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 7.680549e-01 | 0.115 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 7.680549e-01 | 0.115 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 7.680549e-01 | 0.115 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 7.680549e-01 | 0.115 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 7.680549e-01 | 0.115 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 7.681967e-01 | 0.115 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 7.681967e-01 | 0.115 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 7.681967e-01 | 0.115 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 7.681967e-01 | 0.115 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 7.681967e-01 | 0.115 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 7.681967e-01 | 0.115 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 7.681967e-01 | 0.115 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 7.681967e-01 | 0.115 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 7.681967e-01 | 0.115 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.691825e-01 | 0.114 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 7.699781e-01 | 0.114 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 7.722188e-01 | 0.112 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.753343e-01 | 0.111 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 7.753343e-01 | 0.111 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 7.753343e-01 | 0.111 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 7.795976e-01 | 0.108 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 7.801430e-01 | 0.108 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 7.831358e-01 | 0.106 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 7.873072e-01 | 0.104 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 7.873072e-01 | 0.104 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 7.873072e-01 | 0.104 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 7.873072e-01 | 0.104 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 7.873072e-01 | 0.104 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 7.873072e-01 | 0.104 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 7.873072e-01 | 0.104 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 7.873072e-01 | 0.104 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 7.873072e-01 | 0.104 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 7.873072e-01 | 0.104 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 7.873072e-01 | 0.104 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 7.892437e-01 | 0.103 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 7.895914e-01 | 0.103 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 7.895914e-01 | 0.103 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 7.895914e-01 | 0.103 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.913032e-01 | 0.102 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 7.917067e-01 | 0.101 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 7.963266e-01 | 0.099 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.017191e-01 | 0.096 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.023879e-01 | 0.096 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 8.027594e-01 | 0.095 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 8.027594e-01 | 0.095 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 8.039880e-01 | 0.095 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.048432e-01 | 0.094 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.048432e-01 | 0.094 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 8.048432e-01 | 0.094 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 8.048432e-01 | 0.094 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.048432e-01 | 0.094 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 8.048432e-01 | 0.094 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 8.048432e-01 | 0.094 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 8.048432e-01 | 0.094 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 8.048432e-01 | 0.094 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 8.048432e-01 | 0.094 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 8.077230e-01 | 0.093 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 8.146555e-01 | 0.089 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 8.147986e-01 | 0.089 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 8.183165e-01 | 0.087 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.193762e-01 | 0.087 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.209343e-01 | 0.086 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.209343e-01 | 0.086 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 8.209343e-01 | 0.086 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 8.209343e-01 | 0.086 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 8.209343e-01 | 0.086 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.209343e-01 | 0.086 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 8.209343e-01 | 0.086 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 8.209343e-01 | 0.086 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.209343e-01 | 0.086 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 8.240752e-01 | 0.084 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 8.241762e-01 | 0.084 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 8.242149e-01 | 0.084 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 8.256477e-01 | 0.083 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.264805e-01 | 0.083 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.264805e-01 | 0.083 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 8.265072e-01 | 0.083 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.265072e-01 | 0.083 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.265072e-01 | 0.083 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 8.314884e-01 | 0.080 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 8.329927e-01 | 0.079 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 8.329927e-01 | 0.079 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 8.329927e-01 | 0.079 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.349390e-01 | 0.078 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 8.356996e-01 | 0.078 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 8.356996e-01 | 0.078 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.356996e-01 | 0.078 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 8.356996e-01 | 0.078 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 8.356996e-01 | 0.078 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 8.356996e-01 | 0.078 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 8.356996e-01 | 0.078 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 8.404784e-01 | 0.075 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 8.421446e-01 | 0.075 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 8.430502e-01 | 0.074 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.451067e-01 | 0.073 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 8.453821e-01 | 0.073 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 8.479433e-01 | 0.072 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.479433e-01 | 0.072 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 8.492482e-01 | 0.071 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 8.492482e-01 | 0.071 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 8.492482e-01 | 0.071 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 8.492482e-01 | 0.071 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 8.492482e-01 | 0.071 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 8.492482e-01 | 0.071 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.492482e-01 | 0.071 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 8.508231e-01 | 0.070 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 8.515478e-01 | 0.070 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 8.556496e-01 | 0.068 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 8.575132e-01 | 0.067 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.577322e-01 | 0.067 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 8.577322e-01 | 0.067 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 8.582674e-01 | 0.066 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 8.582674e-01 | 0.066 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 8.591508e-01 | 0.066 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 8.605133e-01 | 0.065 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 8.615328e-01 | 0.065 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 8.616803e-01 | 0.065 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 8.616803e-01 | 0.065 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 8.616803e-01 | 0.065 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 8.616803e-01 | 0.065 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 8.616803e-01 | 0.065 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 8.643002e-01 | 0.063 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 8.653925e-01 | 0.063 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 8.669416e-01 | 0.062 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 8.669416e-01 | 0.062 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 8.669416e-01 | 0.062 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.669416e-01 | 0.062 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 8.670355e-01 | 0.062 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 8.670355e-01 | 0.062 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 8.670355e-01 | 0.062 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 8.670355e-01 | 0.062 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 8.722080e-01 | 0.059 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 8.730878e-01 | 0.059 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 8.730878e-01 | 0.059 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 8.730878e-01 | 0.059 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 8.730878e-01 | 0.059 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 8.730878e-01 | 0.059 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 8.730878e-01 | 0.059 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 8.730878e-01 | 0.059 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 8.730878e-01 | 0.059 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 8.730878e-01 | 0.059 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 8.730878e-01 | 0.059 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 8.745285e-01 | 0.058 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.745285e-01 | 0.058 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 8.756004e-01 | 0.058 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.756004e-01 | 0.058 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.763483e-01 | 0.057 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 8.813158e-01 | 0.055 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 8.816447e-01 | 0.055 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 8.835552e-01 | 0.054 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 8.835552e-01 | 0.054 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 8.835552e-01 | 0.054 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 8.835552e-01 | 0.054 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 8.835552e-01 | 0.054 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 8.835552e-01 | 0.054 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 8.835552e-01 | 0.054 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 8.837367e-01 | 0.054 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.837367e-01 | 0.054 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 8.849493e-01 | 0.053 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 8.893187e-01 | 0.051 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.913779e-01 | 0.050 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 8.931598e-01 | 0.049 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 8.931598e-01 | 0.049 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 8.931598e-01 | 0.049 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 8.931598e-01 | 0.049 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 8.931598e-01 | 0.049 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 8.984997e-01 | 0.046 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.985502e-01 | 0.046 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.985502e-01 | 0.046 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 8.985502e-01 | 0.046 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 9.019727e-01 | 0.045 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.019727e-01 | 0.045 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.019727e-01 | 0.045 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.019727e-01 | 0.045 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.019727e-01 | 0.045 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.038858e-01 | 0.044 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.052789e-01 | 0.043 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 9.052789e-01 | 0.043 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 9.052789e-01 | 0.043 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 9.100591e-01 | 0.041 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.100591e-01 | 0.041 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.100591e-01 | 0.041 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.100591e-01 | 0.041 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.115884e-01 | 0.040 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.115884e-01 | 0.040 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.115884e-01 | 0.040 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 9.115884e-01 | 0.040 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.151045e-01 | 0.039 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 9.172511e-01 | 0.038 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.174789e-01 | 0.037 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.174789e-01 | 0.037 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.174789e-01 | 0.037 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.174789e-01 | 0.037 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.174789e-01 | 0.037 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.174789e-01 | 0.037 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 9.175021e-01 | 0.037 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.175021e-01 | 0.037 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.176384e-01 | 0.037 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.180636e-01 | 0.037 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.193499e-01 | 0.037 | 1 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 9.212070e-01 | 0.036 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.221343e-01 | 0.035 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.227687e-01 | 0.035 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.230423e-01 | 0.035 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.230423e-01 | 0.035 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.242871e-01 | 0.034 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.242871e-01 | 0.034 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.242871e-01 | 0.034 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.242871e-01 | 0.034 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.242871e-01 | 0.034 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 9.305339e-01 | 0.031 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 9.305339e-01 | 0.031 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.305339e-01 | 0.031 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.305339e-01 | 0.031 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.305339e-01 | 0.031 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.305339e-01 | 0.031 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 9.305339e-01 | 0.031 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.305339e-01 | 0.031 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.305339e-01 | 0.031 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.311180e-01 | 0.031 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 9.330866e-01 | 0.030 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.332324e-01 | 0.030 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 9.352428e-01 | 0.029 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.352428e-01 | 0.029 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 9.362656e-01 | 0.029 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.362656e-01 | 0.029 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.362656e-01 | 0.029 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.362656e-01 | 0.029 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.362656e-01 | 0.029 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.362656e-01 | 0.029 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.368010e-01 | 0.028 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.369784e-01 | 0.028 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.376305e-01 | 0.028 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.376305e-01 | 0.028 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.391385e-01 | 0.027 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.400627e-01 | 0.027 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 9.415248e-01 | 0.026 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 9.415248e-01 | 0.026 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.415248e-01 | 0.026 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 9.415248e-01 | 0.026 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.415248e-01 | 0.026 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.415248e-01 | 0.026 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.415248e-01 | 0.026 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 9.415248e-01 | 0.026 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 9.415248e-01 | 0.026 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.415248e-01 | 0.026 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.415248e-01 | 0.026 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.418805e-01 | 0.026 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 9.418805e-01 | 0.026 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.458542e-01 | 0.024 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.458542e-01 | 0.024 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 9.462870e-01 | 0.024 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 9.462870e-01 | 0.024 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.463502e-01 | 0.024 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.463502e-01 | 0.024 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.463502e-01 | 0.024 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 9.463502e-01 | 0.024 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 9.463502e-01 | 0.024 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.463502e-01 | 0.024 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.463502e-01 | 0.024 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.464231e-01 | 0.024 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.493897e-01 | 0.023 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 9.495609e-01 | 0.022 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.495681e-01 | 0.022 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 9.507777e-01 | 0.022 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 9.507777e-01 | 0.022 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.507777e-01 | 0.022 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 9.507777e-01 | 0.022 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.526480e-01 | 0.021 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.530382e-01 | 0.021 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.546302e-01 | 0.020 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 9.548401e-01 | 0.020 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.548401e-01 | 0.020 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.548401e-01 | 0.020 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.555579e-01 | 0.020 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.570207e-01 | 0.019 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.571393e-01 | 0.019 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 9.590310e-01 | 0.018 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 9.593054e-01 | 0.018 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.593054e-01 | 0.018 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 9.619873e-01 | 0.017 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.619873e-01 | 0.017 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.621302e-01 | 0.017 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.647662e-01 | 0.016 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.649078e-01 | 0.016 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 9.651251e-01 | 0.015 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.656027e-01 | 0.015 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.656565e-01 | 0.015 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.659583e-01 | 0.015 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.672252e-01 | 0.014 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.672252e-01 | 0.014 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.680040e-01 | 0.014 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.680040e-01 | 0.014 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.680040e-01 | 0.014 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.680040e-01 | 0.014 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.684969e-01 | 0.014 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.685413e-01 | 0.014 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 9.688979e-01 | 0.014 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.688979e-01 | 0.014 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.706455e-01 | 0.013 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.706455e-01 | 0.013 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.706455e-01 | 0.013 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 9.706455e-01 | 0.013 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.706455e-01 | 0.013 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.706455e-01 | 0.013 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.706455e-01 | 0.013 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.716568e-01 | 0.012 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.716568e-01 | 0.012 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.730690e-01 | 0.012 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.730690e-01 | 0.012 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.730690e-01 | 0.012 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.730690e-01 | 0.012 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.730690e-01 | 0.012 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.730690e-01 | 0.012 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.734781e-01 | 0.012 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.734781e-01 | 0.012 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 9.736500e-01 | 0.012 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.752926e-01 | 0.011 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.752926e-01 | 0.011 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.752926e-01 | 0.011 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.760832e-01 | 0.011 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.765189e-01 | 0.010 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.767422e-01 | 0.010 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.772378e-01 | 0.010 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.773327e-01 | 0.010 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.773327e-01 | 0.010 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.773327e-01 | 0.010 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.773327e-01 | 0.010 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.773327e-01 | 0.010 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.773327e-01 | 0.010 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.780277e-01 | 0.010 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.781306e-01 | 0.010 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.781306e-01 | 0.010 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.788497e-01 | 0.009 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.792045e-01 | 0.009 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.803506e-01 | 0.009 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.805930e-01 | 0.009 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.809218e-01 | 0.008 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.809218e-01 | 0.008 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.817480e-01 | 0.008 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.817480e-01 | 0.008 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.818018e-01 | 0.008 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.821528e-01 | 0.008 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.824973e-01 | 0.008 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.824973e-01 | 0.008 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.824973e-01 | 0.008 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.828294e-01 | 0.008 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.839167e-01 | 0.007 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.839429e-01 | 0.007 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.839429e-01 | 0.007 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.843931e-01 | 0.007 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.852691e-01 | 0.006 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.852691e-01 | 0.006 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.852691e-01 | 0.006 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.852691e-01 | 0.006 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.852691e-01 | 0.006 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.852691e-01 | 0.006 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.857971e-01 | 0.006 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.866571e-01 | 0.006 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.866571e-01 | 0.006 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.868319e-01 | 0.006 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.872417e-01 | 0.006 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.872483e-01 | 0.006 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.876022e-01 | 0.005 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.880832e-01 | 0.005 | 0 | 0 |
| Translation | R-HSA-72766 | 9.881152e-01 | 0.005 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.886264e-01 | 0.005 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.886264e-01 | 0.005 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.886264e-01 | 0.005 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.886264e-01 | 0.005 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.891561e-01 | 0.005 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.895660e-01 | 0.005 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.895660e-01 | 0.005 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.895660e-01 | 0.005 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.902064e-01 | 0.004 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.904281e-01 | 0.004 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.904281e-01 | 0.004 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.906669e-01 | 0.004 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.906669e-01 | 0.004 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.909262e-01 | 0.004 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.912190e-01 | 0.004 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.913431e-01 | 0.004 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.918196e-01 | 0.004 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.918645e-01 | 0.004 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.923165e-01 | 0.003 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.923165e-01 | 0.003 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.926166e-01 | 0.003 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.926166e-01 | 0.003 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.926166e-01 | 0.003 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.931091e-01 | 0.003 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.937811e-01 | 0.003 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.937811e-01 | 0.003 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.942951e-01 | 0.002 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.946568e-01 | 0.002 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.947667e-01 | 0.002 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.948825e-01 | 0.002 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.949040e-01 | 0.002 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.949040e-01 | 0.002 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.951992e-01 | 0.002 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.952759e-01 | 0.002 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.955088e-01 | 0.002 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.956245e-01 | 0.002 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.958585e-01 | 0.002 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.959602e-01 | 0.002 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.962941e-01 | 0.002 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.967471e-01 | 0.001 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.968816e-01 | 0.001 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.968860e-01 | 0.001 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.971395e-01 | 0.001 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.973515e-01 | 0.001 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.973760e-01 | 0.001 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.977921e-01 | 0.001 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.979747e-01 | 0.001 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.983173e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.984369e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.985662e-01 | 0.001 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.985662e-01 | 0.001 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.986417e-01 | 0.001 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.986651e-01 | 0.001 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.987366e-01 | 0.001 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.988934e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.988934e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.989850e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.990690e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.991333e-01 | 0.000 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.991371e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.991460e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.992167e-01 | 0.000 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.993956e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.993956e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.994456e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.994595e-01 | 0.000 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.996076e-01 | 0.000 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.998035e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.998035e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.998479e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.998610e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999017e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.999017e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999241e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999600e-01 | 0.000 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.999620e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999685e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999732e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999753e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999843e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999854e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999906e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999923e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999926e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.999948e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999960e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999976e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999979e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999983e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999989e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999989e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.999992e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999992e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999995e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999996e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999996e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999996e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999996e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999999e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.999999e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 1.000000e+00 | 0.000 | 1 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 1.000000e+00 | 0.000 | 1 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 1.000000e+00 | 0.000 | 1 | 1 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 1.000000e+00 | 0.000 | 1 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 1.000000e+00 | 0.000 | 1 | 1 |
| Diseases of cellular response to stress | R-HSA-9675132 | 1.000000e+00 | 0.000 | 1 | 0 |